Date,Open,High,Low,Close,Volume,Dividends,Stock Splits,SMA_10,SMA_40,SMA_120,Close_10_%_D,10_40_%_D,40_120_%_D,RSI,earningsGrowth,revenueGrowth,profitMargins,grossMargins,returnOnEquity,debtToEquity,priceToBook,forwardPE,longName,sector,longBusinessSummary
2022-06-27,14.89606761932373,14.935896873474121,13.362648963928223,14.935896873474121,18548,0.0,0.0,,,,,,,,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-06-28,14.935896873474121,15.413846015930176,14.537606239318848,15.413846015930176,7518,0.0,0.0,,,,,,,100.0,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-06-29,16.40957260131836,16.40957260131836,13.442307472229004,14.557520866394043,11264,0.0,0.0,,,,,,,34.13567782905078,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-06-30,14.637179374694824,14.935896873474121,13.721111297607422,14.836323738098145,5938,0.0,0.0,,,,,,,46.49253044691039,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-01,14.836323738098145,16.927349090576172,14.438034057617188,16.56888771057129,15001,0.0,0.0,,,,,,,76.27742869249329,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-04,17.36547088623047,17.36547088623047,15.135042190551758,16.389657974243164,7155,0.0,0.0,,,,,,,71.82339877028984,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-05,16.389657974243164,17.10658073425293,15.095212936401367,15.91170883178711,8205,0.0,0.0,,,,,,,61.50883446947146,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-06,15.91170883178711,16.5290584564209,15.39393138885498,16.5290584564209,3671,0.0,0.0,,,,,,,67.9177425110481,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-07,14.995640754699707,16.489229202270508,14.995640754699707,15.891794204711914,3596,0.0,0.0,,,,,,,57.30992849996074,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-08,15.891794204711914,15.891794204711914,14.716836929321289,15.154956817626953,26161,0.0,0.0,15.618965148925781,,,-2.9708007340725837,,,47.9788962996158,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-11,15.075299263000488,15.632905006408691,14.139315605163574,14.139315605163574,9785,0.0,0.0,15.539307022094727,,,-9.009355532653807,,,38.640091246673606,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-12,15.712564468383789,15.712564468383789,14.477863311767578,15.115127563476562,3485,0.0,0.0,15.509435176849365,,,-2.5423724905300102,,,48.92617279775233,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-13,15.115127563476562,15.433759689331055,14.457947731018066,15.135042190551758,3899,0.0,0.0,15.567187309265137,,,-2.77599999362877,,,49.11365379371792,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-14,15.433759689331055,15.433759689331055,14.637179374694824,14.876152992248535,2705,0.0,0.0,15.571170234680176,,,-4.463487534698552,,,46.713034116097425,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-15,14.318547248840332,16.03119659423828,14.29863166809082,16.03119659423828,18999,0.0,0.0,15.517401123046875,,,3.3110922835416208,,,56.847412030213455,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-18,16.03119659423828,16.03119659423828,14.736751556396484,14.915982246398926,10335,0.0,0.0,15.370033550262452,,,-2.954133459622623,,,47.46175737502462,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-19,14.915982246398926,15.3142728805542,14.338460922241211,15.254528999328613,31188,0.0,0.0,15.304315567016602,,,-0.3253106450267321,,,50.1523241449282,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-20,15.254528999328613,17.72393035888672,14.836323738098145,17.72393035888672,19843,0.0,0.0,15.423802757263184,,,14.912843724874447,,,64.45235043776451,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-21,15.39393138885498,16.5290584564209,15.39393138885498,16.509145736694336,16296,0.0,0.0,15.485537910461426,,,6.61008892394626,,,55.949230146692706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-22,16.5290584564209,18.401025772094727,15.9515380859375,18.38111114501953,19727,0.0,0.0,15.808153343200683,,,16.27614399961217,,,63.86137761750271,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-25,18.34128189086914,18.34128189086914,15.99136734008789,16.708290100097656,17691,0.0,0.0,16.06505079269409,,,4.0039668451972235,,,54.44959529308833,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-26,16.72820472717285,16.72820472717285,15.433759689331055,15.931623458862305,14448,0.0,0.0,16.146700382232666,,,-1.3320178010302675,,,50.71262588901729,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-27,16.40957260131836,16.40957260131836,14.975726127624512,16.170597076416016,9727,0.0,0.0,16.250255870819093,,,-0.49020024691501485,,,51.808585498634805,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-28,16.170597076416016,16.210426330566406,15.573162078857422,15.891794204711914,4608,0.0,0.0,16.35181999206543,,,-2.8133002172035826,,,50.40051054921832,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-07-29,16.210426330566406,17.02692222595215,15.732478141784668,17.02692222595215,8078,0.0,0.0,16.451392555236815,,,3.4983644623575074,,,55.68178331954388,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-01,16.927349090576172,16.927349090576172,16.03119659423828,16.64854621887207,4476,0.0,0.0,16.62464895248413,,,0.14374599100554264,,,53.63181424364044,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-02,16.64854621887207,16.64854621887207,15.692648887634277,15.692648887634277,10099,0.0,0.0,16.6684609413147,,,-5.854242074994212,,,48.748979306575755,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-03,16.60871696472168,16.72820472717285,15.174871444702148,16.011281967163086,4323,0.0,0.0,16.497196102142333,,,-2.945434678539983,,,50.370974625985916,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-04,16.429487228393555,18.401025772094727,16.40957260131836,17.624357223510742,64672,0.0,0.0,16.608717250823975,,,6.1151018308556,,,57.67399924647667,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-05,17.60444450378418,18.102306365966797,17.425212860107422,17.903162002563477,23125,0.0,0.0,16.56092233657837,,,8.104860579054117,,,58.8024147569664,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-08,17.903162002563477,18.420940399169922,17.72393035888672,18.401025772094727,19846,0.0,0.0,16.730195903778075,,,9.98691155755886,,,60.811575166390405,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-09,18.02264976501465,18.02264976501465,16.329914093017578,16.60871696472168,24035,0.0,0.0,16.797905254364014,,,-1.1262612020816374,,,51.14199692571666,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-10,17.88324737548828,17.88324737548828,16.628631591796875,17.425212860107422,15729,0.0,0.0,16.923366832733155,,,2.965402997727361,,,54.67757376346824,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-11,17.325641632080078,18.34128189086914,17.14640998840332,17.684101104736328,17414,0.0,0.0,17.102597522735596,,,3.4000892626263415,,,55.77047238193083,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-12,17.704017639160156,18.898887634277344,17.325641632080078,18.420940399169922,348441,0.0,0.0,17.241999340057372,,,6.837612250532812,,,58.81454967594481,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-15,18.938716888427734,21.8561954498291,18.938716888427734,20.760896682739258,73542,0.0,0.0,17.65323438644409,,,17.60392587707066,,,66.6616195836377,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-16,20.66132354736328,20.910255432128906,19.436580657958984,19.96431541442871,29110,0.0,0.0,18.080401039123537,,,10.419649272317793,,,62.30927351899766,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-17,19.87470054626465,20.11367416381836,17.923076629638672,18.122222900390625,42601,0.0,0.0,18.29149513244629,,,-0.9254149583179888,,,53.59488473898074,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-18,18.22179412841797,18.500598907470703,17.823503494262695,18.122222900390625,8447,0.0,0.0,18.341281700134278,,,-1.194348373930974,,,53.59488473898074,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-19,17.72393035888672,20.014102935791016,17.425212860107422,18.659914016723633,8899,0.0,0.0,18.416956901550293,16.601249432563783,,1.319203364986364,10.937173592639072,,55.69262196267245,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-22,18.659914016723633,18.659914016723633,16.927349090576172,17.783674240112305,35504,0.0,0.0,18.35522174835205,16.672443866729736,,-3.113814238125781,10.09316867445173,,51.599056187316556,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-23,17.743846893310547,17.823503494262695,17.325641632080078,17.823503494262695,2628,0.0,0.0,18.476700401306154,16.73268530368805,,-3.5352465151044106,10.422804624394058,,51.772581174253304,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-24,18.938716888427734,18.938716888427734,17.743846893310547,18.54042625427246,9381,0.0,0.0,18.588221740722656,16.83225793838501,,-0.25712780446063505,10.432134588035694,,54.906427599134155,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-25,19.715383529663086,19.715383529663086,17.903162002563477,17.923076629638672,10928,0.0,0.0,18.612119293212892,16.909426760673522,,-3.702118241985946,10.06948701832604,,51.78582751819921,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-26,17.923076629638672,18.54042625427246,17.425212860107422,17.923076629638672,25438,0.0,0.0,18.562332916259766,16.943281483650207,,-3.4438359095538837,9.555713479539952,,51.78582751819921,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-29,17.923076629638672,17.923076629638672,16.927349090576172,17.923076629638672,16136,0.0,0.0,18.278550910949708,16.981616950035097,,-1.9447618306443,7.637281919210472,,51.78582751819921,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-30,19.41666603088379,19.41666603088379,17.425212860107422,17.923076629638672,20633,0.0,0.0,18.0744270324707,17.031901144981383,,-0.8373731712774567,6.121018896334478,,51.78582751819921,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-08-31,17.425212860107422,18.520511627197266,17.425212860107422,18.420940399169922,11771,0.0,0.0,18.104298782348632,17.07919819355011,,1.7489858106518308,6.002041648451905,,54.585623291910004,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-01,18.420940399169922,18.679828643798828,17.743846893310547,18.30145263671875,8941,0.0,0.0,18.122221755981446,17.13943965435028,,0.9890116297586238,5.734038693509558,,53.778466987269674,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-02,17.923076629638672,18.401025772094727,17.72393035888672,18.30145263671875,8533,0.0,0.0,18.086375617980956,17.218102049827575,,1.1891659405987953,5.0427948773951865,,53.778466987269674,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-05,16.5290584564209,17.903162002563477,16.5290584564209,17.76375961303711,6811,0.0,0.0,18.084384155273437,17.308713150024413,,-1.7729359179910629,4.481390375620902,,49.92560834813965,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-06,17.704017639160156,17.743846893310547,17.2260684967041,17.34555435180664,10798,0.0,0.0,18.036589241027833,17.364473819732666,,-3.8312947086985587,3.8706351155391068,,47.099242644242096,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-07,17.743846893310547,18.201879501342773,17.2260684967041,17.863332748413086,8065,0.0,0.0,17.968879890441894,17.4326810836792,,-0.5873885443741604,3.075825251370507,,50.81205328831024,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-08,18.420940399169922,18.420940399169922,16.827777862548828,17.38538360595703,22924,0.0,0.0,17.91511058807373,17.495411849021913,,-2.956872521174074,2.3989074545580404,,47.49814843593874,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-09,16.827777862548828,16.827777862548828,16.03119659423828,16.429487228393555,27876,0.0,0.0,17.76575164794922,17.505369114875794,,-7.521575478681848,1.487443831459436,,41.64783029542437,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-12,16.429487228393555,17.72393035888672,15.254528999328613,16.389657974243164,36585,0.0,0.0,17.612409782409667,17.5422110080719,,-6.942558248830448,0.4001706187747211,,41.41891355801688,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-13,17.704017639160156,17.704017639160156,16.588802337646484,17.18623924255371,12093,0.0,0.0,17.53872604370117,17.590503764152526,,-2.0097628543211767,-0.29435041284532265,,47.61994222212581,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-14,17.166324615478516,17.923076629638672,16.309999465942383,17.484956741333008,12919,0.0,0.0,17.44512767791748,17.584529423713683,,0.22831052974146343,-0.7927522109759284,,49.76731748456238,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-15,16.867605209350586,16.927349090576172,16.36974334716797,16.927349090576172,9562,0.0,0.0,17.307717323303223,17.59498450756073,,-2.1976799460141434,-1.6326651730444397,,45.978130600885706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-16,18.91880226135254,18.91880226135254,15.931623458862305,15.931623458862305,12633,0.0,0.0,17.070734405517577,17.5337473154068,,-6.672887759808918,-2.640695691344747,,40.10586928909611,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-19,15.832051277160645,17.405298233032227,15.832051277160645,16.748119354248047,13413,0.0,0.0,16.969170379638673,17.53474304676056,,-1.302662537090588,-3.225440290819512,,46.17638929456552,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-20,16.907434463500977,16.907434463500977,15.015555381774902,16.290084838867188,15058,0.0,0.0,16.863623428344727,17.54370458126068,,-3.4010400665940166,-3.8764968354653115,,43.51210476330117,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-21,15.49350357055664,16.349828720092773,15.49350357055664,16.309999465942383,11407,0.0,0.0,16.708290100097656,17.54718964099884,,-2.3837905121897873,-4.780819937918173,,43.6643006720726,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-22,16.309999465942383,17.206153869628906,15.99136734008789,16.768033981323242,13295,0.0,0.0,16.646555137634277,17.569095635414122,,0.7297536498367043,-5.250927634091054,,47.18870033835552,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-23,16.867605209350586,16.927349090576172,15.234615325927734,15.732478141784668,36868,0.0,0.0,16.57685422897339,17.536734533309936,,-5.09370520802977,-5.4735407125728806,,40.95098173327935,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-26,15.712564468383789,16.011281967163086,15.433759689331055,15.433759689331055,8534,0.0,0.0,16.48126440048218,17.506364870071412,,-6.355730274677699,-5.855587251821353,,39.33570151435559,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-27,15.931623458862305,15.931623458862305,14.736751556396484,14.935896873474121,20747,0.0,0.0,16.25623016357422,17.487446069717407,,-8.12201400210613,-7.040570139485691,,36.73496972072302,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-28,15.931623458862305,15.931623458862305,14.776580810546875,15.39393138885498,7509,0.0,0.0,16.047127628326415,17.472012305259703,,-4.070486971876582,-8.155240804771797,,40.62443265796762,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-29,15.413846015930176,15.413846015930176,14.816410064697266,15.334188461303711,10226,0.0,0.0,15.88781156539917,17.41475808620453,,-3.484577481401857,-8.768117898892672,,40.27661481545787,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-09-30,15.334188461303711,15.433759689331055,15.334188461303711,15.413846015930176,822,0.0,0.0,15.836033821105957,17.352525186538696,,-2.665994591480965,-8.739312285275712,,41.00193121492337,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-03,15.413846015930176,15.931623458862305,14.557520866394043,15.49350357055664,6567,0.0,0.0,15.710572242736816,17.279837131500244,,-1.381672601267145,-9.081479627506091,,41.76359329544715,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-04,15.49350357055664,16.807863235473633,14.955810546875,16.2303409576416,8765,0.0,0.0,15.704597854614258,17.270377731323244,,3.3477017870462173,-9.066274641284389,,48.39960214004697,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-05,16.827777862548828,17.18623924255371,15.712564468383789,15.772307395935059,9043,0.0,0.0,15.650828647613526,17.229055094718934,,0.7761809362091243,-9.160261189188299,,44.969252518881625,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-06,17.18623924255371,17.18623924255371,15.851964950561523,16.130769729614258,4030,0.0,0.0,15.587102222442628,17.19022181034088,,3.4879318773495087,-9.325764411800003,,48.07120909881984,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-07,16.130769729614258,17.007007598876953,15.573162078857422,16.329914093017578,5092,0.0,0.0,15.646845817565918,17.13794615268707,,4.365533369574168,-8.700577781237588,,49.765324829367096,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-10,16.210426330566406,16.309999465942383,15.49350357055664,15.891794204711914,672,0.0,0.0,15.692649269104004,17.01621859073639,,1.2690332409326848,-7.778281141457217,,46.1947577888439,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-11,15.832051277160645,16.130769729614258,15.632905006408691,16.130769729614258,1865,0.0,0.0,15.812136554718018,16.920379948616027,,2.0151177786354637,-6.549754776568455,,48.37072099792941,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-12,18.102306365966797,18.102306365966797,15.692648887634277,16.429487228393555,9327,0.0,0.0,15.915692138671876,16.8780615568161,,3.2282296317686496,-5.701895415564337,,51.03630902480602,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-13,15.9515380859375,17.30572509765625,15.9515380859375,17.30572509765625,3679,0.0,0.0,16.112845802307127,16.85764911174774,,7.4032812700182316,-4.418192029644128,,57.902274815707756,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-14,17.30572509765625,17.504871368408203,16.051111221313477,16.56888771057129,11238,0.0,0.0,16.22834997177124,16.80537345409393,,2.0984125890334138,-3.433565364666876,,51.37790997090588,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-17,14.65709400177002,17.38538360595703,14.65709400177002,15.891794204711914,9858,0.0,0.0,16.26817903518677,16.758076453208922,,-2.3136260650977882,-2.9233511339444025,,46.22362643474779,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-18,15.931623458862305,16.907434463500977,15.115127563476562,16.807863235473633,10224,0.0,0.0,16.32593126296997,16.732685446739197,,2.951941697787052,-2.430896015250759,,53.081648151358785,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-19,16.807863235473633,17.285810470581055,15.5930757522583,16.03119659423828,2309,0.0,0.0,16.351820182800292,16.669954705238343,,-1.9607822552944891,-1.9084306350159463,,47.54549779208408,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-20,16.03119659423828,16.03119659423828,14.955810546875,15.891794204711914,7024,0.0,0.0,16.32792263031006,16.619172644615173,,-2.6710588693539354,-1.7524940653377359,,46.60593681816855,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-21,17.126495361328125,17.126495361328125,15.652819633483887,16.2303409576416,1814,0.0,0.0,16.31796531677246,16.576854252815245,,-0.5369809129376882,-1.5617494857253535,,49.22989408557706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-24,16.2303409576416,16.2303409576416,15.035470008850098,16.090940475463867,1844,0.0,0.0,16.337879943847657,16.531050848960877,,-1.5114535621054037,-1.1685337301189338,,48.1799635642237,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-25,16.429487228393555,16.429487228393555,15.274443626403809,15.931623458862305,5156,0.0,0.0,16.31796531677246,16.481264519691468,,-2.3675859729463604,-0.9908171956338659,,46.947631028869765,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-26,15.931623458862305,16.907434463500977,15.174871444702148,15.174871444702148,5343,0.0,0.0,16.19250373840332,16.400112795829774,,-6.284588906950082,-1.265900180145368,,41.51574789930643,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-27,15.672735214233398,15.931623458862305,15.513418197631836,15.632905006408691,3687,0.0,0.0,16.025221729278563,16.333399105072022,,-2.448120403557956,-1.8867926621456315,,45.617103878282464,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-28,15.931623458862305,15.931623458862305,14.89606761932373,15.5930757522583,16428,0.0,0.0,15.927640533447265,16.26568968296051,,-2.1005294568671036,-2.078295824537802,,45.319483249302216,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-10-31,15.632905006408691,16.847692489624023,15.035470008850098,16.847692489624023,3624,0.0,0.0,16.023230361938477,16.242788004875184,,5.145417678347623,-1.3517238719781821,,55.2284998070302,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-01,16.827777862548828,16.827777862548828,14.955810546875,15.553247451782227,14277,0.0,0.0,15.897768783569337,16.197980332374573,,-2.1671049345187345,-1.8533887722113733,,45.97196865142772,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-02,15.832051277160645,16.11085319519043,15.135042190551758,15.99136734008789,12706,0.0,0.0,15.893785858154297,16.151181197166444,,0.6139599640039776,-1.5936626298100376,,49.082577941076444,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-03,16.807863235473633,16.807863235473633,15.413846015930176,15.672735214233398,2672,0.0,0.0,15.871879959106446,16.108364987373353,,-1.2547016823850694,-1.4680883407613214,,46.96480161185631,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-04,15.931623458862305,16.40957260131836,15.035470008850098,15.931623458862305,2089,0.0,0.0,15.842008209228515,16.095918393135072,,0.5656811210436404,-1.5774818044234737,,48.894236207442624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-07,16.36974334716797,16.36974334716797,15.533332824707031,15.931623458862305,12353,0.0,0.0,15.82607650756836,16.08446753025055,,0.6669179897081285,-1.6064630190351408,,48.894236207442624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-08,15.015555381774902,16.807863235473633,15.015555381774902,16.509145736694336,12270,0.0,0.0,15.883828735351562,16.067540192604064,,3.936815309214762,-1.1433701428490237,,53.290621348807406,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-09,16.509145736694336,16.887521743774414,15.513418197631836,16.708290100097656,8602,0.0,0.0,16.037170600891113,16.048123526573182,,4.184774957555497,-0.06825050706977025,,54.73658419254972,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-10,16.2303409576416,17.02692222595215,16.071025848388672,16.927349090576172,22243,0.0,0.0,16.16661500930786,16.048123526573182,,4.7055866724748565,0.7383510136775562,,56.33775211416929,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-11,16.927349090576172,17.007007598876953,16.11085319519043,16.907434463500977,13092,0.0,0.0,16.29805088043213,16.07251880168915,,3.738996690705449,1.4032155228791965,,56.143313116811576,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-14,17.325641632080078,18.859058380126953,17.325641632080078,18.321367263793945,23390,0.0,0.0,16.44541835784912,16.111849999427797,,11.407121820342535,2.070329344135967,,65.30027098743416,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-15,19.854785919189453,24.793588638305664,18.361196517944336,21.756622314453125,58895,0.0,0.0,17.06575584411621,16.248513436317445,,27.487012665508114,5.029644164075512,,77.55949393825341,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-16,22.30427360534668,23.399572372436523,20.910255432128906,21.408119201660156,25724,0.0,0.0,17.60743103027344,16.375966429710388,,21.58570529029466,7.5199506902312905,,74.67707874094424,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-17,23.399572372436523,23.399572372436523,18.91880226135254,19.57598114013672,47506,0.0,0.0,17.99775562286377,16.446165108680724,,8.769012927745395,9.43436055718592,,61.69590086106903,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-18,19.57598114013672,21.8561954498291,18.142135620117188,20.760896682739258,28990,0.0,0.0,18.480682945251466,16.57187557220459,,12.338362950345852,11.518354483957447,,65.83258860680098,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-21,20.81068229675293,20.81068229675293,18.321367263793945,18.460769653320312,34441,0.0,0.0,18.733597564697266,16.64755082130432,,-1.4563562093972136,12.530652501287904,,53.70734940159439,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-22,18.71965789794922,21.059614181518555,18.162050247192383,20.46217918395996,4055,0.0,0.0,19.128900909423827,16.785707879066468,,6.969968012533833,13.959453168368105,,60.52106010601225,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-23,21.208974838256836,21.258760452270508,19.41666603088379,21.009828567504883,25889,0.0,0.0,19.55905475616455,16.926105308532716,,7.417402473823967,15.55555397794035,,62.16221173411624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-24,21.009828567504883,21.65705108642578,19.795042037963867,21.65705108642578,10524,0.0,0.0,20.032024955749513,17.084176874160768,,8.112141105384653,17.25484407766384,,64.06352800146428,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-25,20.910255432128906,21.80640983581543,20.910255432128906,21.65705108642578,2417,0.0,0.0,20.506986618041992,17.240257000923158,,5.608159257157585,18.9482651966494,,64.06352800146428,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-28,21.65705108642578,21.65705108642578,19.755212783813477,20.81068229675293,7313,0.0,0.0,20.755918121337892,17.373186469078064,,0.2638484845377085,19.470991451571855,,59.52705426801663,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-29,19.91452980041504,20.312820434570312,19.23743438720703,20.11367416381836,15999,0.0,0.0,20.591623306274414,17.470269799232483,,-2.3210853041897876,17.8666588605235,,56.00956609428235,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-11-30,20.711111068725586,20.711111068725586,18.699743270874023,18.99846076965332,18154,0.0,0.0,20.35065746307373,17.55092363357544,,-6.644486527641533,15.952059777311753,,50.83378914657598,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-01,18.898887634277344,19.96431541442871,18.440853118896484,19.87470054626465,24048,0.0,0.0,20.380529403686523,17.6445219039917,,-2.4819220708289276,15.50627166087091,,54.39939716901347,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-02,19.87470054626465,19.87470054626465,18.819229125976562,19.53615379333496,5359,0.0,0.0,20.258055114746092,17.724677896499635,,-3.563527284934921,14.292937976304563,,52.805976988403955,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-05,21.8561954498291,21.8561954498291,18.321367263793945,18.83914566040039,13507,0.0,0.0,20.2958927154541,17.798361682891844,,-7.177546095050482,14.032364759521299,,49.58567686765433,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-06,18.83914566040039,18.83914566040039,17.982820510864258,18.460769653320312,9415,0.0,0.0,20.095751762390137,17.856611680984496,,-8.135958925058715,12.539557455853176,,47.87870604180189,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-07,18.420940399169922,18.95863151550293,17.823503494262695,17.84341812133789,3999,0.0,0.0,19.779110717773438,17.891959953308106,,-9.786550184463758,10.54747925543177,,45.14783966465314,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-08,19.018375396728516,19.018375396728516,17.783674240112305,17.923076629638672,1144,0.0,0.0,19.405713272094726,17.907393741607667,,-7.640206889937278,8.36704409422644,,45.57916756258682,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-09,17.5247859954834,18.95863151550293,16.98709487915039,18.520511627197266,17155,0.0,0.0,19.092059326171874,17.956184339523315,17.120935742060343,-2.993640912225308,6.325814912405347,4.878521887159756,48.82914016878797,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-12,18.978546142578125,18.978546142578125,17.166324615478516,17.8035888671875,13729,0.0,0.0,18.791349983215333,18.003979206085205,17.144833175341287,-5.256467028234342,4.373315299453374,5.011107556179626,45.3307083310366,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-13,17.8035888671875,18.002735137939453,17.8035888671875,18.002735137939453,2802,0.0,0.0,18.580256080627443,18.033851003646852,17.16640725135803,-3.1082507161466806,3.0298857236321592,5.053146762670435,46.47783792017212,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-14,17.923076629638672,18.02264976501465,17.18623924255371,17.903162002563477,8937,0.0,0.0,18.470726203918456,18.08065013885498,17.194287594159444,-3.072776863719491,2.1574227810824618,5.154982664106517,45.95857149335411,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-15,17.166324615478516,17.942991256713867,16.489229202270508,17.88324737548828,15983,0.0,0.0,18.27158088684082,18.13043646812439,17.21967862447103,-2.1253416097794577,0.7784943234244749,5.289052505074486,45.8482445165547,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-16,17.8035888671875,17.8035888671875,16.11085319519043,16.827777862548828,27154,0.0,0.0,18.000743293762206,18.14537239074707,17.221836042404174,-6.516205537022712,-0.7970577504301641,5.362589366597931,40.3232827599477,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-19,17.34555435180664,17.34555435180664,15.931623458862305,16.329914093017578,13504,0.0,0.0,17.749820137023924,18.151346731185914,17.221338176727294,-7.999551730919223,-2.2121035981981696,5.400326878868348,37.99728827119495,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-20,16.170597076416016,16.170597076416016,14.935896873474121,15.433759689331055,26845,0.0,0.0,17.447119140625,18.138900136947633,17.217355267206827,-11.539781639972341,-3.8137979210411252,5.35241827469306,34.17583195615177,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-21,15.672735214233398,17.086666107177734,15.433759689331055,15.672735214233398,26474,0.0,0.0,17.23005084991455,18.151346731185914,17.2102192401886,-9.038369353906326,-5.075633752775377,5.468422440544112,36.02361615362314,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-22,16.011281967163086,16.787948608398438,15.652819633483887,16.130769729614258,3051,0.0,0.0,17.05082015991211,18.16379334926605,17.21221070289612,-5.39593064538307,-6.127427063019923,5.528532405252389,39.52752712666264,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-23,16.887521743774414,16.887521743774414,16.130769729614258,16.509145736694336,3376,0.0,0.0,16.849683570861817,18.186695098876953,17.223495610555013,-2.0210340018276294,-7.351591483477929,5.592357730980385,42.337097663142565,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-27,16.509145736694336,16.509145736694336,15.115127563476562,15.812135696411133,27965,0.0,0.0,16.65053825378418,18.16080617904663,17.237435777982075,-5.035288016485011,-8.316084156026896,5.356773553546789,38.764255834597535,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-28,15.851964950561523,15.851964950561523,15.274443626403809,15.632905006408691,5248,0.0,0.0,16.413555240631105,18.162797617912293,17.24175059000651,-4.756131275507848,-9.630908266885447,5.341957726958597,37.87903895708103,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-29,15.632905006408691,17.007007598876953,14.935896873474121,15.174871444702148,27195,0.0,0.0,16.140726184844972,18.14238522052765,17.242082500457762,-5.983960876863735,-11.033053324310696,5.221542815642982,35.63920487523829,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2022-12-30,15.174871444702148,15.612991333007812,14.79649543762207,14.79649543762207,10514,0.0,0.0,15.832050991058349,18.120479226112366,17.24141868750254,-6.540880609979979,-12.628960892801866,5.098539479509375,33.85809626111522,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-02,15.632905006408691,15.772307395935059,14.736751556396484,15.075299263000488,24263,0.0,0.0,15.656803131103516,18.09907112121582,17.233452876408894,-3.7140651462099723,-13.49388581190483,5.0228950113176944,36.38104681127914,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-03,14.736751556396484,15.891794204711914,14.736751556396484,14.816410064697266,17365,0.0,0.0,15.505452728271484,18.071190786361694,17.232623108228047,-4.443873233819671,-14.197946822776997,4.866163861804975,35.044299507954435,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-04,14.816410064697266,15.792222023010254,14.477863311767578,14.856239318847656,10157,0.0,0.0,15.447700691223144,18.029868125915527,17.229304027557372,-3.8287987591029373,-14.321610211784428,4.646526041201052,35.4373320593823,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-05,15.194786071777344,15.194786071777344,14.856239318847656,14.995640754699707,1677,0.0,0.0,15.379991245269775,17.98705189228058,17.206568280855816,-2.499029319592606,-14.49409643461175,4.5359632361621856,36.87695561176195,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-09,14.995640754699707,15.154956817626953,14.418119430541992,15.154956817626953,24415,0.0,0.0,15.282409954071046,17.94274208545685,17.19528337319692,-0.833985849268103,-14.826786890851459,4.346882200412174,38.56302068019114,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-10,15.154956817626953,15.812135696411133,14.457947731018066,15.812135696411133,35793,0.0,0.0,15.212708950042725,17.915359616279602,17.173875244458518,3.9403024690531843,-15.08566238202102,4.317513439841355,45.07972226707562,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-11,15.792222023010254,16.469316482543945,14.955810546875,15.91170883178711,25016,0.0,0.0,15.222666263580322,17.85511815547943,17.167237067222594,4.526424978883604,-14.743402250134393,4.006941161022403,46.01409812638594,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-12,16.270170211791992,16.270170211791992,15.712564468383789,15.712564468383789,3733,0.0,0.0,15.230632209777832,17.704016709327696,17.165411575635275,3.1642301643694317,-13.970753305077455,3.1377350395543187,44.38757290224918,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-13,16.60871696472168,16.60871696472168,14.995640754699707,15.413846015930176,4249,0.0,0.0,15.254529666900634,17.55415987968445,17.15910531679789,1.0443871591480611,-13.10020091274885,2.302302804213333,41.9898816728535,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-16,15.413846015930176,16.329914093017578,14.975726127624512,15.871879577636719,23200,0.0,0.0,15.3620680809021,17.461557340621948,17.158939361572266,3.31863844145053,-12.023493774153065,1.7636170434135339,46.74048729855988,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-17,16.309999465942383,16.309999465942383,15.652819633483887,15.931623458862305,3975,0.0,0.0,15.447700500488281,17.340825510025024,17.149811871846516,3.1326536811011274,-10.917156212905175,1.1137943646605195,47.34618494460359,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-18,16.708290100097656,16.708290100097656,15.254528999328613,15.254528999328613,39642,0.0,0.0,15.491512393951416,17.26066949367523,17.138195061683653,-1.529762805569141,-10.24964356320061,0.7146285332309975,41.57539120085431,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-19,15.095212936401367,15.931623458862305,15.055383682250977,15.433759689331055,18121,0.0,0.0,15.549264430999756,17.134959006309508,17.136037651697794,-0.7428309048396231,-9.254148636864908,-0.0062946021140402545,43.53721787724034,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-20,15.433759689331055,15.91170883178711,15.234615325927734,15.712564468383789,17830,0.0,0.0,15.620956802368164,17.002527403831483,17.133548339207966,0.5864408126507127,-8.12567783982506,-0.7647040343456375,46.54420872025184,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-23,15.91170883178711,15.91170883178711,15.035470008850098,15.413846015930176,10596,0.0,0.0,15.646845722198487,16.846447277069093,17.115127412478127,-1.4891161477852985,-7.120798439819828,-1.5698401123975758,43.84968021254648,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-24,15.095212936401367,15.254528999328613,14.935896873474121,15.075299263000488,8176,0.0,0.0,15.573162078857422,16.68190348148346,17.09156188964844,-3.1969282367698892,-6.646372243171865,-2.39684594544335,40.955841822605734,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-25,14.856239318847656,15.812135696411133,14.517691612243652,14.65709400177002,40185,0.0,0.0,15.447700595855713,16.528063774108887,17.060362458229065,-5.11795648277774,-6.53653805441843,-3.1200901236621967,37.65037591141088,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-26,15.891794204711914,15.891794204711914,14.617263793945312,14.617263793945312,14747,0.0,0.0,15.338170528411865,16.39065351486206,17.043767015139263,-4.70008292795527,-6.421238698602624,-3.8319785743202814,37.34126550821623,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-27,14.517691612243652,14.915982246398926,14.438034057617188,14.816410064697266,20312,0.0,0.0,15.278426933288575,16.28610224723816,17.02202699184418,-3.0239819230647944,-6.187332602068539,-4.323367275581377,39.99393850657313,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-30,14.836323738098145,14.836323738098145,14.019828796386719,14.75666618347168,39741,0.0,0.0,15.16690559387207,16.158151388168335,16.99763170083364,-2.7048326229850086,-6.134648515684142,-4.9388075200154695,39.4543006786829,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-01-31,14.69692325592041,14.876152992248535,14.69692325592041,14.836323738098145,1719,0.0,0.0,15.057375621795654,16.040655636787413,16.967759895324708,-1.4680638196840554,-6.129924095725358,-5.463916652856153,40.60503758879372,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-01,14.199058532714844,14.75666618347168,13.920255661010742,13.920255661010742,20379,0.0,0.0,14.923948287963867,15.917683386802674,16.91075455347697,-6.725382637264972,-6.24296309136737,-5.8724237498326985,32.86833487504056,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-02,13.940170288085938,14.716836929321289,13.940170288085938,14.358375549316406,21280,0.0,0.0,14.816409873962403,15.815123534202575,16.864038387934368,-3.0913988512893584,-6.314927974355081,-6.219831985690063,38.867591015926074,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-03,14.65709400177002,14.65709400177002,14.338460922241211,14.637179374694824,7521,0.0,0.0,14.708871364593506,15.734967565536499,16.834996358553568,-0.48740646458609443,-6.521120534054352,-6.534178978055813,42.39549592505741,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-06,14.438034057617188,14.856239318847656,14.378290176391602,14.736751556396484,11655,0.0,0.0,14.641161918640137,15.655309438705444,16.806784097353617,0.6528828674085585,-6.477978120049019,-6.851249185913462,43.64630700729677,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-07,14.816410064697266,14.935896873474121,14.557520866394043,14.617263793945312,5794,0.0,0.0,14.59535837173462,15.557728242874145,16.773095345497133,0.1500848533675981,-6.185799469664325,-7.245932116812671,42.454971940139224,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-08,14.617263793945312,15.374016761779785,14.537606239318848,14.995640754699707,31013,0.0,0.0,14.629213047027587,15.487529540061951,16.749861733118692,2.5047670472375265,-5.541984541912489,-7.5363738111389456,47.355319213908494,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-09,14.995640754699707,15.3142728805542,14.557520866394043,14.975726127624512,11310,0.0,0.0,14.665059280395507,15.411854314804078,16.726130255063374,2.1184152159842218,-4.845588461676711,-7.857621100741074,47.12784675264895,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-10,14.517691612243652,15.135042190551758,14.497776985168457,15.035470008850098,6076,0.0,0.0,14.686965274810792,15.340162014961242,16.696922286351523,2.3728845783888164,-4.2580824082130855,-8.125810542337673,47.935834743884875,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-13,14.477863311767578,15.174871444702148,14.477863311767578,14.975726127624512,3847,0.0,0.0,14.708871269226075,15.26747398376465,16.67236103216807,1.8142442986549983,-3.6587762660187906,-8.426443295540423,47.15970615296301,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-14,14.039743423461914,15.015555381774902,14.039743423461914,14.876152992248535,2939,0.0,0.0,14.712854194641114,15.218683362007141,16.646970001856484,1.109905633856548,-3.3237380352416706,-8.579859516116503,45.8279126337169,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-15,14.75666618347168,15.374016761779785,14.497776985168457,14.836323738098145,4178,0.0,0.0,14.804461002349854,15.181343603134156,16.621247061093648,0.21522388247186824,-2.4825378480103426,-8.663029029452069,45.27711855595822,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-16,15.35410213470459,15.35410213470459,14.537606239318848,14.935896873474121,4330,0.0,0.0,14.862213134765625,15.168897032737732,16.596353896458943,0.49577904744304474,-2.0217943157648004,-8.601026904022447,46.992348847917974,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-17,14.935896873474121,14.935896873474121,14.398204803466797,14.69692325592041,7228,0.0,0.0,14.868187522888183,15.144501733779908,16.5653204202652,-1.151883958311178,-1.824518335095859,-8.577067333675785,43.470726074335964,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-20,15.3142728805542,15.3142728805542,14.318547248840332,14.915982246398926,5428,0.0,0.0,14.886110591888428,15.114132046699524,16.537108167012533,0.20066796041925591,-1.5086639054532316,-8.604745799217165,47.364662860277264,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-21,14.637179374694824,14.935896873474121,13.7410249710083,14.418119430541992,32701,0.0,0.0,14.866196155548096,15.061856389045715,16.504747056961058,-3.014064393593248,-1.2990446094010077,-8.742276770044699,40.53123492982251,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-22,15.135042190551758,15.135042190551758,14.139315605163574,14.438034057617188,6627,0.0,0.0,14.810435485839843,15.027503848075867,16.47703267733256,-2.514452924619982,-1.444473842299613,-8.797268644437468,40.89854220617088,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-23,14.935896873474121,15.254528999328613,14.438034057617188,14.915982246398926,9456,0.0,0.0,14.804461097717285,15.009580779075623,16.456786243120828,0.7532942127750705,-1.3665916748606948,-8.793973760521784,49.034524869131765,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-24,15.035470008850098,16.429487228393555,15.035470008850098,16.290084838867188,15469,0.0,0.0,14.929922580718994,15.037461113929748,16.443675843874612,9.110310189449695,-0.7151375647524489,-8.551705490282387,64.26537321914863,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-27,17.8035888671875,17.8035888671875,16.051111221313477,16.56888771057129,7098,0.0,0.0,15.089238739013672,15.08177092075348,16.436871711413065,9.805988208881217,0.049515526388986354,-8.244274302625735,66.45579754718992,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-02-28,16.588802337646484,17.206153869628906,16.588802337646484,16.807863235473633,6121,0.0,0.0,15.282409763336181,15.125085020065308,16.4400248448054,9.981760048059606,1.0401577449790362,-7.998405337906635,68.2521603230267,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-01,16.927349090576172,16.927349090576172,16.03119659423828,16.588802337646484,9874,0.0,0.0,15.457657623291016,15.169394826889038,16.441684381167093,7.317698075102283,1.900292000383617,-7.738194729825748,64.82514387892587,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-02,16.588802337646484,17.206153869628906,16.03119659423828,17.206153869628906,7513,0.0,0.0,15.684683322906494,15.228142690658569,16.441850336392722,9.700358721941168,2.998006004553544,-7.381819083024426,69.47656390128824,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-03,16.927349090576172,17.2260684967041,16.19051170349121,17.18623924255371,28499,0.0,0.0,15.933614921569824,15.28290765285492,16.439361023902894,7.861519982437705,4.257745211156518,-7.03466131905301,69.15885793363898,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-06,17.18623924255371,17.624357223510742,16.708290100097656,17.504871368408203,30627,0.0,0.0,16.19250383377075,15.341655516624451,16.444173709551492,8.104784461439534,5.546000666123075,-6.704612906677402,71.41144368177243,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-07,17.504871368408203,18.420940399169922,16.907434463500977,16.927349090576172,5909,0.0,0.0,16.44342679977417,15.369535851478577,16.45247142314911,2.9429528084051726,6.987139746268145,-6.582206063867159,62.50095725167457,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-08,16.927349090576172,17.206153869628906,16.250255584716797,16.250255584716797,12913,0.0,0.0,16.62464895248413,15.377999520301818,16.448322558403014,-2.2520377352773457,8.106707446157102,-6.507186579669763,53.99451708696725,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-09,17.8035888671875,17.8035888671875,16.5290584564209,16.5290584564209,3812,0.0,0.0,16.785956573486327,15.398411870002747,16.45031400521596,-1.5304347770755196,9.010959800254605,-6.394419795753957,56.613024665210574,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-10,16.40957260131836,17.10658073425293,16.051111221313477,16.051111221313477,6156,0.0,0.0,16.762059211730957,15.41434350013733,16.448156603177388,-4.2414119973989965,8.743257288781844,-6.285282466488377,51.229892079393466,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-13,16.19051170349121,17.88324737548828,16.051111221313477,16.68837547302246,1725,0.0,0.0,16.774007987976074,15.434755897521972,16.44749278227488,-0.5105071788149593,8.676859545728975,-6.157393702244483,57.08876428986146,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-14,16.68837547302246,16.887521743774414,15.732478141784668,16.170597076416016,8404,0.0,0.0,16.710281372070312,15.440730237960816,16.45114377339681,-3.229654149069741,8.222092572981577,-6.1419044739608815,51.65861103493646,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-15,15.692648887634277,16.290084838867188,14.935896873474121,14.975726127624512,8780,0.0,0.0,16.548973751068115,15.433760166168213,16.447326827049256,-9.506617432045061,7.225806108770051,-6.16250088260016,41.78191763943364,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-16,14.975726127624512,15.851964950561523,13.979998588562012,15.473588943481445,12704,0.0,0.0,16.37571725845337,15.434755897521972,16.451807594299318,-5.508939246653359,6.096379930974278,-6.18200578232973,46.381875354151035,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-17,15.632905006408691,15.931623458862305,14.617263793945312,14.935896873474121,6445,0.0,0.0,16.15068302154541,15.41533920764923,16.447990640004477,-7.521577548458698,4.770208452703375,-6.278283195539107,42.47822486386763,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-20,15.39393138885498,16.489229202270508,15.075299263000488,16.309999465942383,10328,0.0,0.0,16.031195831298827,15.437743043899536,16.456122398376465,1.7391318625103906,3.8441680607827178,-6.1884527218720775,53.296181230781706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-21,16.2303409576416,16.309999465942383,14.935896873474121,16.309999465942383,10897,0.0,0.0,15.96946086883545,15.468610548973084,16.463590343793232,2.132436404108654,3.237849438879407,-6.0435164751001915,53.296181230781706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-22,16.250255584716797,16.250255584716797,15.553247451782227,16.051111221313477,4347,0.0,0.0,15.949546432495117,15.50346097946167,16.46823707421621,0.6367879440849474,2.8773281890050386,-5.858405428623917,51.1924912026539,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-23,15.49350357055664,15.871879577636719,15.433759689331055,15.632905006408691,5290,0.0,0.0,15.859931087493896,15.528852009773255,16.463258441289266,-1.4314443097689284,2.1320254550192965,-5.675707727290202,47.9031242112105,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-24,15.931623458862305,16.051111221313477,15.35410213470459,15.374016761779785,6931,0.0,0.0,15.792221641540527,15.542792177200317,16.459939352671306,-2.648170024796752,1.6047918642706775,-5.571996079816319,45.93541794124606,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-27,15.154956817626953,16.429487228393555,15.154956817626953,15.5930757522583,3141,0.0,0.0,15.682691669464111,15.563702416419982,16.455458569526673,-0.5714319907232636,0.7645305073334799,-5.419211803420082,47.88608679870298,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-28,15.692648887634277,16.36974334716797,15.234615325927734,16.36974334716797,5153,0.0,0.0,15.702606296539306,15.602037906646729,16.455790479977924,4.2485752876303895,0.6445849605950128,-5.188158991024911,54.19612141849553,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-29,16.907434463500977,16.907434463500977,15.772307395935059,16.548973083496094,4466,0.0,0.0,15.859930992126465,15.667755842208862,16.461266970634462,4.344546591732954,1.2265646200579894,-4.820474206761592,55.53414649689893,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-30,15.832051277160645,16.927349090576172,15.832051277160645,16.628631591796875,4133,0.0,0.0,15.975435256958008,15.724512243270874,16.465415819485983,4.088754543037388,1.5957443372815145,-4.49975624264701,56.14729430484617,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-03-31,16.628631591796875,16.887521743774414,16.329914093017578,16.429487228393555,6244,0.0,0.0,16.124794292449952,15.769319939613343,16.465415819485983,1.88959270064157,2.2542148564291544,-4.227624054588686,54.13747472151207,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-03,16.18055534362793,17.275854110717773,15.234615325927734,16.5290584564209,11226,0.0,0.0,16.146700191497803,15.814127612113953,16.458943597475688,2.368027277328338,2.1030093315365215,-3.917724011525444,55.004727412590334,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-04,16.5290584564209,19.26730728149414,16.329914093017578,16.977136611938477,12278,0.0,0.0,16.21341390609741,15.873124432563781,16.462345671653747,4.710437359240243,2.1438090212127685,-3.579205848559823,58.78200694693566,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-05,17.275854110717773,18.76944351196289,16.8775634765625,16.8775634765625,3025,0.0,0.0,16.296059131622314,15.920172500610352,16.470560415585837,3.5683740482493898,2.361071345160056,-3.341646556571693,57.6243199757569,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-06,18.420940399169922,18.420940399169922,16.578845977783203,17.37542724609375,3591,0.0,0.0,16.47031135559082,15.980165028572083,16.475290115674337,5.495438859421989,3.0672169288763222,-3.005258685133561,61.68728165970714,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-11,17.923076629638672,17.923076629638672,16.977136611938477,17.126495361328125,952,0.0,0.0,16.645559215545653,16.032440662384033,16.484417605400086,2.8892759897986204,3.8242371581024686,-2.7418435630264004,58.658873204624896,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-12,17.425212860107422,17.972862243652344,16.578845977783203,16.578845977783203,5801,0.0,0.0,16.744136238098143,16.072518658638,16.490143036842348,-0.9871531022236488,4.178670398364663,-2.532569773781159,52.54701050268248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-13,17.873289108276367,17.873289108276367,17.076709747314453,17.076709747314453,5541,0.0,0.0,16.814832878112792,16.12753257751465,16.49719611008962,1.5574158310103439,4.261658113507029,-2.240765825344629,56.93950746357239,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-14,17.02692222595215,17.674144744873047,16.578845977783203,16.8775634765625,12688,0.0,0.0,16.847691917419432,16.17856357097626,16.50375130176544,0.17730356947103568,4.135894657814769,-1.970386761429177,54.75613892948665,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-17,16.8775634765625,17.923076629638672,16.479272842407227,17.773717880249023,9418,0.0,0.0,16.962200546264647,16.24950909614563,16.51910208861033,4.78426918589337,4.3859260356860075,-1.6320075450746325,61.84615198449175,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-18,17.923076629638672,17.923076629638672,17.076709747314453,17.873289108276367,7551,0.0,0.0,17.10658073425293,16.328918242454527,16.54158890247345,4.481949876097906,4.762486285077423,-1.2856725026404316,62.548404656788165,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-19,17.873289108276367,17.873289108276367,17.275854110717773,17.773717880249023,3857,0.0,0.0,17.231046676635742,16.400361633300783,16.55942900975545,3.1493803818029846,5.065041014999701,-0.9605849112367294,61.33268972889473,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-20,17.873289108276367,17.873289108276367,16.329914093017578,16.8775634765625,7458,0.0,0.0,17.221089363098145,16.461847734451293,16.570133074124655,-1.9947976535779548,4.612128850262132,-0.653497103426746,51.610063902018005,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-21,16.827777862548828,17.773717880249023,16.479272842407227,16.777990341186523,3888,0.0,0.0,17.211132049560547,16.520346641540527,16.569552222887676,-2.5166369482656017,4.181421994397107,-0.2969638568698355,50.64931659928893,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-24,16.927349090576172,17.17628288269043,16.5290584564209,17.076709747314453,3393,0.0,0.0,17.181260299682616,16.574364829063416,16.58224774201711,-0.6085150364091433,3.6616514531826834,-0.04753826547723848,53.4490049110504,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-25,17.674144744873047,17.674144744873047,16.479272842407227,16.479272842407227,7935,0.0,0.0,17.116538047790527,16.579094529151917,16.586313621203104,-3.7230963621499478,3.241694036387783,-0.043524391350943,47.629263696109255,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-26,16.479272842407227,17.873289108276367,16.479272842407227,17.823503494262695,34964,0.0,0.0,17.241003799438477,16.6104599237442,16.604236690203347,3.37857181403318,3.7960651215498875,0.03747979300082061,58.5620078368818,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-27,17.823503494262695,17.823503494262695,16.977136611938477,17.72393035888672,4749,0.0,0.0,17.305725860595704,16.633361601829527,16.619172581036885,2.4165672197734636,4.042263222920748,0.08537742010593535,57.60274687642052,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-04-28,17.02692222595215,17.2260684967041,16.777990341186523,17.2260684967041,2795,0.0,0.0,17.340576362609863,16.64929325580597,16.6299596230189,-0.6603463662987893,4.15202673280338,0.11625784563123961,52.93393523097393,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-02,17.2260684967041,17.2260684967041,15.931623458862305,16.72820472717285,16236,0.0,0.0,17.236025047302245,16.63734452724457,16.63178511460622,-2.946272813689587,3.5984139120116465,0.03342643378350235,48.68441894708707,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-03,16.72820472717285,17.823503494262695,16.2303409576416,17.37542724609375,6470,0.0,0.0,17.186238861083986,16.64207422733307,16.637344590822856,1.100813194434047,3.269812562530077,0.02842783284552275,53.86913196546119,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-04,17.37542724609375,17.37542724609375,16.827777862548828,16.827777862548828,3362,0.0,0.0,17.091644859313966,16.625146889686583,16.636514830589295,-1.5438361780688752,2.8059780326920025,-0.06833126420090126,49.32763112797336,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-05,16.777990341186523,16.777990341186523,15.881836891174316,16.5290584564209,10429,0.0,0.0,17.056794357299804,16.615189623832702,16.63336169719696,-3.0939922814573313,2.657837457561529,-0.10925075577068023,47.000058011008186,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-08,15.632905006408691,17.873289108276367,15.632905006408691,16.37969970703125,18088,0.0,0.0,17.016965293884276,16.618425726890564,16.617181134223937,-3.7448838605908934,2.398178825981261,0.007489794186953794,45.83548474505042,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-09,16.329914093017578,16.329914093017578,15.48354721069336,15.881836891174316,4269,0.0,0.0,16.897478008270262,16.6022451877594,16.56822458902995,-6.010607716718749,1.7782704518093273,0.20533641698687044,42.091559687577075,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-10,15.881836891174316,17.72393035888672,15.832051277160645,16.329914093017578,2316,0.0,0.0,16.8825421333313,16.609215259552002,16.525906213124593,-3.273369827537193,1.6456338816013951,0.5041118190616786,46.33976709005298,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-11,16.080982208251953,16.329914093017578,15.284400939941406,16.280128479003906,4472,0.0,0.0,16.72820463180542,16.59900908470154,16.49844077428182,-2.678566903405658,0.778332889900956,0.6095625143952139,45.93653252114107,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-12,15.433759689331055,16.2303409576416,15.433759689331055,15.68269157409668,981,0.0,0.0,16.524080753326416,16.586811447143553,16.456122398376465,-5.091897042807411,-0.37819621943034887,0.7941667277583083,41.29295466566233,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-15,16.130769729614258,16.130769729614258,15.533332824707031,15.931623458862305,6343,0.0,0.0,16.394636249542238,16.6107088804245,16.435046180089316,-2.824172391704397,-1.300803189302181,1.068829977173997,43.840326038022674,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-16,15.931623458862305,15.931623458862305,15.383974075317383,15.832051277160645,11011,0.0,0.0,16.305020904541017,16.61967043876648,16.396461780865987,-2.90076063164475,-1.8932357015426873,1.3613221003629477,43.03592001964854,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-17,16.37969970703125,16.37969970703125,15.48354721069336,16.03119659423828,7101,0.0,0.0,16.17059783935547,16.647052931785584,16.354973181088766,-0.862066118408548,-2.8620987413356507,1.785877283091783,45.20156110070723,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-19,15.732478141784668,15.931623458862305,15.383974075317383,15.832051277160645,1920,0.0,0.0,16.07102518081665,16.63510422706604,16.306431516011557,-1.4869860570018911,-3.390895774080023,2.0156017012781406,43.42370363829678,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-22,15.931623458862305,16.130769729614258,15.383974075317383,15.732478141784668,1466,0.0,0.0,15.991367149353028,16.620666193962098,16.257060074806212,-1.6189297959982998,-3.7862444096114487,2.236604389002482,42.52311727498594,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-23,15.184828758239746,15.632905006408691,14.98568344116211,15.284400939941406,3156,0.0,0.0,15.881837272644043,16.601498436927795,16.211007730166116,-3.7617583057075015,-4.334916917396819,2.408799707343529,38.639589976135355,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-24,15.184828758239746,15.284400939941406,15.035470008850098,15.035470008850098,6545,0.0,0.0,15.797200584411621,16.58656256198883,16.16868936220805,-4.821933933745104,-4.759045007831691,2.5844593239418643,36.637700154282555,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-25,15.135042190551758,15.832051277160645,14.786538124084473,15.08525562286377,17541,0.0,0.0,15.67273473739624,16.57934353351593,16.136079319318135,-3.748414838737138,-5.468303339555867,2.7470378982775574,37.3369444270388,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-26,15.08525562286377,15.632905006408691,14.935896873474121,15.48354721069336,3654,0.0,0.0,15.593076610565186,16.576605319976807,16.09948637485504,-0.702423278018234,-5.933233556730401,2.963566253063539,42.777540178443736,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-29,15.48354721069336,16.280128479003906,15.035470008850098,15.881836891174316,1320,0.0,0.0,15.61299114227295,16.564407658576965,16.069033734003703,1.7219362161389644,-5.74374004742256,3.082786014226854,47.67042199700684,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-30,15.881836891174316,15.881836891174316,15.184828758239746,15.68269157409668,11269,0.0,0.0,15.588097953796387,16.54275062084198,16.042729949951173,0.6068323446559746,-5.770821847745429,3.1168053844372485,45.57218850072944,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-05-31,15.035470008850098,15.832051277160645,14.039743423461914,15.832051277160645,14845,0.0,0.0,15.588097953796387,16.522836112976073,16.020823963483174,1.5649973722730175,-5.6572500797583825,3.1334976942331587,47.44072760181749,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-01,15.832051277160645,18.271581649780273,14.48781967163086,14.935896873474121,10817,0.0,0.0,15.478567981719971,16.485496354103088,15.996594619750976,-3.505951641564898,-6.1079651516376785,3.056286328269302,38.827680037904344,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-02,14.935896873474121,15.035470008850098,14.189102172851562,14.88611125946045,10156,0.0,0.0,15.383973979949952,16.444422674179076,15.97128657499949,-3.2362426063536676,-6.448683029135674,2.962416940913232,38.41046421746568,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-05,15.48354721069336,15.881836891174316,14.537606239318848,15.881836891174316,2076,0.0,0.0,15.398909854888917,16.417040181159972,15.949297618865966,3.136111847112851,-6.201667992744829,2.9326843944571395,49.98579040692264,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-07,15.832051277160645,15.832051277160645,14.736751556396484,14.98568344116211,7217,0.0,0.0,15.369038105010986,16.369743180274963,15.925815073649089,-2.494330882840914,-6.113138515635328,2.787474955428806,42.28342911967107,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-08,15.78226375579834,15.78226375579834,14.935896873474121,15.533332824707031,3973,0.0,0.0,15.418824386596679,16.323690819740296,15.905236721038818,0.7426534944511886,-5.543271084559866,2.630920281418781,47.59757655843078,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-09,15.58311939239502,15.58311939239502,14.935896873474121,15.08525562286377,4394,0.0,0.0,15.418824386596679,16.272659826278687,15.881754167874654,-2.1633864902364093,-5.247055175965462,2.4613506434619863,44.025868611166636,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-12,15.08525562286377,15.931623458862305,15.08525562286377,15.08525562286377,5307,0.0,0.0,15.378995227813721,16.235320067405702,15.858437569936116,-1.9100051765326538,-5.274456161237946,2.3765424292747896,44.025868611166636,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-13,15.08525562286377,15.383974075317383,14.935896873474121,15.383974075317383,3193,0.0,0.0,15.329208946228027,16.193001675605775,15.846405871709187,0.3572599817868069,-5.334358302939121,2.18722028643334,47.09534004660475,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-14,14.935896873474121,15.632905006408691,14.935896873474121,15.632905006408691,921,0.0,0.0,15.324230289459228,16.161885213851928,15.840597462654113,2.014291818374624,-5.182903561737759,2.028255259659775,49.5768046968761,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-15,15.334188461303711,15.334188461303711,14.786538124084473,15.08525562286377,2090,0.0,0.0,15.249550724029541,16.094673657417296,15.83769326210022,-1.0773766659688089,-5.250947930828509,1.6225872736911284,44.61845537493721,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-16,15.035470008850098,15.931623458862305,14.686964988708496,15.334188461303711,9251,0.0,0.0,15.2893798828125,16.03119614124298,15.834872039159139,0.2930699533575042,-4.6273294387686414,1.2398212097851964,47.20327273416635,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-19,15.334188461303711,16.130769729614258,14.736751556396484,15.732478141784668,6265,0.0,0.0,15.374016571044923,15.980165147781372,15.831552942593893,2.331606506882943,-3.793130866489232,0.9387089549986392,51.133164251067754,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-20,15.632905006408691,15.632905006408691,14.935896873474121,15.383974075317383,6525,0.0,0.0,15.324230289459228,15.942825412750244,15.822176512082418,0.3898648397319467,-3.8800846605037487,0.7625303672708597,47.78174294577846,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-21,15.931623458862305,15.931623458862305,14.637179374694824,15.184828758239746,11159,0.0,0.0,15.344144821166992,15.902996373176574,15.816948954264323,-1.0382857095266218,-3.514127393955715,0.5440203364192595,45.92922507106999,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-22,13.989956855773926,15.284400939941406,13.940170288085938,14.48781967163086,19181,0.0,0.0,15.239593505859375,15.838274121284485,15.807406576474508,-4.93303075268688,-3.77996119299744,0.19527266955932032,40.073146576817564,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-26,14.139315605163574,14.238887786865234,13.790810585021973,13.940170288085938,14334,0.0,0.0,15.125084972381591,15.774796557426452,15.797117400169373,-7.834102660972208,-4.118668552584214,-0.14129693524137527,36.17080896359168,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-27,14.48781967163086,14.637179374694824,13.790810585021973,13.940170288085938,5119,0.0,0.0,15.010576438903808,15.677713227272033,15.789981357256572,-7.131012957261487,-4.255319501620383,-0.7110086291073681,36.17080896359168,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-28,14.089529037475586,18.07243537902832,13.840598106384277,15.632905006408691,18043,0.0,0.0,15.03546953201294,15.625437593460083,15.794628071784974,3.973507266425671,-3.7756898513617956,-1.0711900119201143,52.686933734527685,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-29,15.931623458862305,15.931623458862305,14.98568344116211,15.433759689331055,5733,0.0,0.0,15.015555000305175,15.580629873275758,15.799772651990255,2.785143066755639,-3.626778105677301,-1.386999569812748,51.014502199317114,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-06-30,14.98568344116211,17.325641632080078,14.388246536254883,16.080982208251953,14619,0.0,0.0,15.115127658843994,15.564449310302734,15.80997884273529,6.3899860537587285,-2.8868458016135303,-1.5530035484226936,55.91260673113333,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-03,17.02692222595215,17.02692222595215,14.388246536254883,14.935896873474121,808,0.0,0.0,15.075298500061034,15.503461050987244,15.80948097705841,-0.9247022643455384,-2.761722363271555,-1.9356734513627603,46.96505400580911,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-04,14.935896873474121,15.184828758239746,14.288675308227539,14.587392807006836,2823,0.0,0.0,14.960789966583253,15.447451424598693,15.80475127696991,-2.4958385246397063,-3.150432033341599,-2.260711643667942,44.624480012105046,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-05,14.98568344116211,15.284400939941406,14.438034057617188,14.736751556396484,3682,0.0,0.0,14.896067714691162,15.402643752098083,15.795789742469788,-1.069518220151166,-3.2888901772977603,-2.4889289917215236,45.86955819407253,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-06,15.035470008850098,15.433759689331055,14.736751556396484,14.98568344116211,4715,0.0,0.0,14.876153182983398,15.367793345451355,15.788072864214579,0.7362807900096217,-3.1991591207430963,-2.6620064549856086,47.96933309504567,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-07,14.836323738098145,14.98568344116211,14.338460922241211,14.98568344116211,5891,0.0,0.0,14.925939559936523,15.34538950920105,15.782015522321066,0.4002688138035045,-2.733393955318148,-2.76660488961299,47.96933309504567,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-10,14.98568344116211,14.98568344116211,14.388246536254883,14.786538124084473,5086,0.0,0.0,15.010576343536377,15.306805109977722,15.776787956555685,-1.4925357582846965,-1.9352749598167214,-2.9789514055215056,46.3028614192898,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-11,15.035470008850098,15.433759689331055,14.786538124084473,15.433759689331055,2883,0.0,0.0,15.15993528366089,15.285645890235902,15.77313695748647,1.8062372994777123,-0.8224095172537856,-3.0906411867500343,52.124140304362896,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-12,14.686964988708496,15.383974075317383,14.338460922241211,14.388246536254883,4680,0.0,0.0,15.035469436645508,15.253284764289855,15.760275483131409,-4.304640457804184,-1.427989649510014,-3.2168899546470326,43.85360263290922,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-13,14.338460922241211,14.98568344116211,14.338460922241211,14.786538124084473,855,0.0,0.0,14.97074728012085,15.22465763092041,15.75637555917104,-1.230460661646348,-1.6677573772423102,-3.3746208082806373,47.28510647260536,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-14,14.786538124084473,15.433759689331055,14.139315605163574,15.433759689331055,2034,0.0,0.0,14.90602502822876,15.21470034122467,15.75637555917104,3.5404117469471634,-2.0287965327818274,-3.4378161139418038,52.37844662191248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-17,14.736751556396484,15.433759689331055,14.388246536254883,14.686964988708496,4881,0.0,0.0,14.881131839752197,15.181094551086426,15.747828896840414,-1.3047855037815037,-1.975896469946977,-3.5988093944029007,46.763919516468135,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-18,14.686964988708496,14.686964988708496,14.238887786865234,14.238887786865234,5266,0.0,0.0,14.846281337738038,15.14126546382904,15.738037578264873,-4.091216763681142,-1.9482131582441997,-3.791909324578111,43.73475037552666,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-19,14.338460922241211,14.736751556396484,14.139315605163574,14.438034057617188,4705,0.0,0.0,14.816409587860107,15.108904361724854,15.732727034886677,-2.5537599240840616,-1.9359098903671563,-3.965127417379851,45.42673559975379,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-20,14.438034057617188,14.88611125946045,13.940170288085938,14.438034057617188,11550,0.0,0.0,14.761644649505616,15.087745189666748,15.730901535352071,-2.192239412152944,-2.1613603362314926,-4.088490060407265,45.42673559975379,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-21,14.438034057617188,14.637179374694824,13.940170288085938,14.587392807006836,8039,0.0,0.0,14.721815586090088,15.076543259620667,15.730652610460917,-0.9130856061684494,-2.3528448625265606,-4.15818317928695,46.817810100135134,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-24,13.641451835632324,14.935896873474121,13.641451835632324,14.736751556396484,6314,0.0,0.0,14.716836929321289,15.067830657958984,15.72998878955841,0.1353186637239836,-2.3294244314611836,-4.209527040724707,48.238699644759876,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-25,13.989956855773926,14.48781967163086,12.944443702697754,14.338460922241211,29110,0.0,0.0,14.607307052612304,15.03920350074768,15.726503745714824,-1.8404907174386684,-2.871804002877573,-4.37033085090143,44.80123531589679,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-26,14.338460922241211,14.438034057617188,13.989956855773926,14.388246536254883,803,0.0,0.0,14.607307052612304,15.001863741874695,15.722769769032796,-1.4996639392080535,-2.6300511459857145,-4.58510833490662,45.32569766395366,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-27,14.438034057617188,15.184828758239746,13.940170288085938,14.438034057617188,1503,0.0,0.0,14.572456645965577,14.970747303962707,15.727084589004516,-0.9224428770944714,-2.6604594273774413,-4.809138532710615,45.87949153623643,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-28,14.537606239318848,15.184828758239746,13.940170288085938,14.836323738098145,5120,0.0,0.0,14.512713050842285,14.945854115486146,15.731067490577697,2.2298428014262854,-2.898068329163349,-4.991481827675483,50.22314878378211,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-07-31,14.039743423461914,15.184828758239746,13.940170288085938,14.98568344116211,10673,0.0,0.0,14.542584896087646,14.947098779678345,15.733971691131591,3.046903616107949,-2.70630367506947,-5.001107964982324,51.785889438039426,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-01,13.7410249710083,15.135042190551758,13.7410249710083,15.08525562286377,4080,0.0,0.0,14.6272216796875,14.952077388763428,15.736875891685486,3.131380334601283,-2.1726459850994284,-4.9870031912541375,52.8486678445641,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-02,14.935896873474121,14.935896873474121,13.940170288085938,14.686964988708496,14103,0.0,0.0,14.652114772796631,14.922205591201783,15.73745673497518,0.23785109830403725,-1.8099926097010648,-5.180323336245108,48.265631419395824,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-03,14.836323738098145,14.836323738098145,14.039743423461914,14.438034057617188,1750,0.0,0.0,14.652114772796631,14.908514356613159,15.732810012499492,-1.4610908971100176,-1.719819813587215,-5.239341574909008,45.60378145333826,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-04,13.940170288085938,14.836323738098145,13.790810585021973,14.388246536254883,707,0.0,0.0,14.632200145721436,14.879887199401855,15.727914349238079,-1.6672380574146735,-1.6645761514265767,-5.391860172975225,45.06842348269547,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-07,14.438034057617188,14.438034057617188,13.790810585021973,14.438034057617188,3410,0.0,0.0,14.602328395843506,14.86370666027069,15.722935716311136,-1.1251242526026448,-1.7584998843244437,-5.464813133778019,45.7542181032518,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-08,14.836323738098145,14.836323738098145,13.790810585021973,14.288675308227539,6467,0.0,0.0,14.597349834442138,14.843792152404784,15.717210292816162,-2.114592920738858,-1.6602382695228006,-5.557081213137356,43.98033345665902,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-09,13.790810585021973,14.139315605163574,13.591666221618652,13.790810585021973,6653,0.0,0.0,14.537606239318848,14.8039630651474,15.70816577275594,-5.136991895385562,-1.7992264953404908,-5.75625901005437,38.60719691217052,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-10,13.641451835632324,14.238887786865234,13.193375587463379,13.541879653930664,11146,0.0,0.0,14.447990798950196,14.75168743133545,15.697378738721211,-6.271537389720448,-2.0587246970820656,-6.024517361315843,36.224216089957004,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-11,13.193375587463379,14.88611125946045,13.04401683807373,14.587392807006836,31559,0.0,0.0,14.423097705841064,14.739240860939026,15.694474538167318,1.139111060027248,-2.1449079913999056,-6.086432998475129,50.143311865300376,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-14,14.637179374694824,18.122222900390625,14.139315605163574,17.425212860107422,82144,0.0,0.0,14.667050647735596,14.79151647090912,15.717210284868877,18.805159119005634,-0.841467630572655,-5.889682692932679,69.5617674002366,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-15,17.425212860107422,18.470726013183594,16.777990341186523,17.823503494262695,7689,0.0,0.0,14.940875434875489,14.84379210472107,15.741439628601075,19.293568653001955,0.65403321111956,-5.702448728063243,71.25403145289063,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-16,17.923076629638672,18.321367263793945,16.678417205810547,17.076709747314453,32412,0.0,0.0,15.179849910736085,14.886110496520995,15.76359454790751,12.495906400476315,1.9732448867938914,-5.56652258924659,64.06225496606694,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-17,17.2260684967041,18.669870376586914,16.329914093017578,17.2260684967041,11756,0.0,0.0,15.458653354644776,14.937141489982604,15.786828168233235,11.433176626140467,3.4913766132021746,-5.382250754843825,64.82688654859467,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-18,17.2260684967041,18.172008514404297,16.280128479003906,16.8775634765625,15109,0.0,0.0,15.707585048675536,14.996885085105896,15.803174678484599,7.448493350577887,4.738983859224668,-5.102073537644521,61.536857181992694,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-21,16.8775634765625,17.425212860107422,15.931623458862305,16.777990341186523,14977,0.0,0.0,15.941580677032471,15.067830586433411,15.807240557670593,5.246717255328975,5.798778301806476,-4.677666342455811,60.590689022722806,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-22,16.777990341186523,17.425212860107422,16.37969970703125,17.425212860107422,28731,0.0,0.0,16.25523443222046,15.154956650733947,15.814376600583394,7.1975487819965265,7.260184287186498,-4.169749883312636,64.42011498450631,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-23,17.425212860107422,17.923076629638672,16.927349090576172,17.773717880249023,13631,0.0,0.0,16.653525161743165,15.208476972579955,15.822425389289856,6.726460059514543,9.501596982844184,-3.880242134846662,66.31801204884775,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-24,17.72393035888672,17.72393035888672,16.927349090576172,17.72393035888672,3790,0.0,0.0,17.07173023223877,15.265731239318848,15.831884789466859,3.8203516443594765,11.830412605904792,-3.576033793049576,65.77819546861255,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-25,17.72393035888672,19.814956665039062,17.17628288269043,18.520511627197266,26103,0.0,0.0,17.465042114257812,15.32671947479248,15.842837770779928,6.043326469151809,13.951600295041514,-3.2577389445933864,69.98750691742387,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-28,18.520511627197266,18.520511627197266,17.425212860107422,17.923076629638672,6836,0.0,0.0,17.514828491210938,15.401398968696594,15.848978082338968,2.330871459190111,13.722321763171639,-2.8240250653203107,63.662816717170244,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-29,18.172008514404297,18.22179412841797,17.5247859954834,18.02264976501465,6526,0.0,0.0,17.534743118286134,15.48728039264679,15.85329290231069,2.782513798104637,13.22028576825831,-2.3087475385669056,64.24280390021926,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-30,18.57029914855957,18.76944351196289,18.02264976501465,18.07243537902832,6752,0.0,0.0,17.63431568145752,15.570672488212585,15.86283528804779,2.4844723520033405,13.253397981411316,-1.8418069312952021,64.54749546190374,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-08-31,18.07243537902832,18.07243537902832,17.425212860107422,18.07243537902832,17149,0.0,0.0,17.71895236968994,15.64784128665924,15.878020119667053,1.9949430528581817,13.235762333533202,-1.4496696141775587,64.54749546190374,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-01,18.71965789794922,19.864742279052734,17.5247859954834,19.21752166748047,17741,0.0,0.0,17.95294818878174,15.7536372423172,15.900423979759216,7.0438206883977035,13.960655007065803,-0.92316241144809,71.11343137971691,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-04,19.21752166748047,20.014102935791016,18.321367263793945,19.366880416870117,18487,0.0,0.0,18.211837196350096,15.86814579963684,15.928055389722187,6.342266340660609,14.769787386040365,-0.37612620385539697,71.84586627165928,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-05,19.814956665039062,19.91452980041504,18.57029914855957,19.91452980041504,16410,0.0,0.0,18.46076889038086,15.980165052413941,15.954940009117127,7.874866527318236,15.523017627356738,0.1581017746378214,74.40817225737645,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-06,20.910255432128906,21.905981063842773,19.91452980041504,21.905981063842773,24138,0.0,0.0,18.873995208740233,16.168108415603637,16.002734875679018,16.064356388617064,16.73595156329592,1.033407984381185,81.13256929645087,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-07,21.905981063842773,26.884614944458008,21.905981063842773,24.395299911499023,73760,0.0,0.0,19.541132164001464,16.408327460289,16.08123132387797,24.84077026222602,19.09277293066215,2.034024197670418,86.0624298833482,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-08,24.494871139526367,26.386751174926758,23.4991455078125,25.291452407836914,41257,0.0,0.0,20.21822624206543,16.654769778251648,16.1630468527476,25.092340470581355,21.396011540592188,3.0422662879335793,87.34443427487028,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-11,25.888887405395508,26.685470581054688,23.399572372436523,23.797863006591797,28701,0.0,0.0,20.805704879760743,16.882542228698732,16.23689657052358,14.381431170552403,23.237985120469617,3.9764104881178786,74.96758857539783,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-12,23.797863006591797,25.59016990661621,22.00555419921875,22.702564239501953,24827,0.0,0.0,21.27369632720947,17.09413414001465,16.290167943636575,6.716594475709103,24.45027137941507,4.935284885703876,67.42247954900529,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-13,22.802135467529297,22.802135467529297,21.208974838256836,21.80640983581543,27908,0.0,0.0,21.647093772888184,17.278343534469606,16.335971363385518,0.7359697546410635,25.284543218527254,5.768693823718774,61.930470019597195,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-14,22.802135467529297,22.802135467529297,21.706836700439453,22.602991104125977,12936,0.0,0.0,22.10014934539795,17.482467460632325,16.390570362408955,2.2752866999640338,26.41321595572188,6.661739488502412,64.68423639572549,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-15,22.602991104125977,25.191879272460938,22.602991104125977,24.19615364074707,14364,0.0,0.0,22.59801254272461,17.72268648147583,16.461930767695108,7.072042707299843,27.508956197721986,7.658613874472296,69.44471479403143,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-18,24.19615364074707,25.191879272460938,24.096580505371094,25.09230613708496,23919,0.0,0.0,23.170555114746094,17.981575345993043,16.54291651248932,8.293936044354137,28.857203381289647,8.696524777947022,71.7513858257673,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-19,25.291452407836914,27.083759307861328,24.096580505371094,26.08803367614746,58385,0.0,0.0,23.787905502319337,18.2753146648407,16.630374495188395,9.669317769922452,30.164136369614127,9.891179360562381,74.0917363618763,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-20,26.08803367614746,26.08803367614746,25.39102554321289,25.39102554321289,14247,0.0,0.0,24.136409950256347,18.55038414001465,16.705551846822104,5.19802073109559,30.112723100931348,11.043228682945236,69.73636604883707,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-21,25.39102554321289,26.187606811523438,24.89316177368164,24.89316177368164,16427,0.0,0.0,24.18619613647461,18.81176233291626,16.77508675257365,2.9230129170286228,28.569539144954682,12.141073309383282,66.71943732675999,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-22,24.096580505371094,25.888887405395508,24.096580505371094,25.689743041992188,17153,0.0,0.0,24.226025199890138,19.08309781551361,16.85059601465861,6.041923221101443,26.950170428805237,13.248800214027511,69.02818585509125,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-25,25.689743041992188,25.888887405395508,25.09230613708496,25.888887405395508,6302,0.0,0.0,24.435127639770506,19.355677914619445,16.92942434946696,5.949466632860425,26.24268572538359,14.331577465768225,69.59604248490854,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-26,25.888887405395508,26.685470581054688,25.490598678588867,25.789316177368164,23000,0.0,0.0,24.74380283355713,19.623279428482057,17.006593163808187,4.225354327480846,26.094126742357492,15.386304825839266,68.9156795790802,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-27,25.191879272460938,26.78504180908203,24.19615364074707,26.486324310302734,11725,0.0,0.0,25.211794281005858,19.918263411521913,17.08583639462789,5.055292832756001,26.576267017444156,16.577631621151376,71.04923895317054,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-28,26.486324310302734,27.681196212768555,25.490598678588867,27.581623077392578,21940,0.0,0.0,25.70965747833252,20.246853137016295,17.175036891301474,7.281176735387103,26.981004427442883,17.885354571032003,74.06209068788058,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-09-29,27.581623077392578,28.4777774810791,25.888887405395508,26.386751174926758,30143,0.0,0.0,25.92871723175049,20.546815752983093,17.25013125737508,1.766512161332038,26.193360292268274,19.11106904881408,65.99358797001365,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-02,26.187606811523438,26.187606811523438,24.89316177368164,24.89316177368164,19732,0.0,0.0,25.908802795410157,20.808193945884703,17.314853477478028,-3.9200615703803994,24.512501482783495,20.175397227302977,57.55322363132071,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-03,25.888887405395508,25.888887405395508,22.50341796875,24.295726776123047,38681,0.0,0.0,25.729572105407716,21.058370232582092,17.379160817464193,-5.572752331094189,22.182162347958965,21.170236317858848,54.54796320906605,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-04,24.295726776123047,24.395299911499023,23.00128173828125,23.89743423461914,9869,0.0,0.0,25.58021297454834,21.31103582382202,17.43600018819173,-6.578439130289962,20.032705993362004,22.224338115427415,52.576886528371126,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-05,23.89743423461914,24.295726776123047,23.00128173828125,23.598716735839844,4883,0.0,0.0,25.45076847076416,21.56245675086975,17.49200979868571,-7.2769973018763965,18.032786174690276,23.270321701339764,51.085915063433,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-06,23.4991455078125,23.4991455078125,21.905981063842773,22.901708602905273,25205,0.0,0.0,25.171965026855467,21.77031464576721,17.534743054707846,-9.018987677474136,15.625177846245034,24.15531027654363,47.68775954388981,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-09,23.20042610168457,26.386751174926758,23.20042610168457,25.888887405395508,24966,0.0,0.0,25.171965026855467,21.981906509399415,17.60153970718384,2.8480985802068703,14.512201278319466,24.88627060522317,59.975586940157065,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-10,25.888887405395508,26.884614944458008,24.69401741027832,26.386751174926758,19867,0.0,0.0,25.231708526611328,22.195987701416016,17.673314984639486,4.577742514333628,13.676890012881227,25.59040406798242,61.594770672954176,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-11,26.685470581054688,27.78076934814453,25.39102554321289,27.28290557861328,13097,0.0,0.0,25.311366653442384,22.451142597198487,17.76002616882324,7.789144506358628,12.739770565622809,26.413904933373605,64.38751061579032,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-12,27.28290557861328,27.28290557861328,24.89316177368164,26.287179946899414,13817,0.0,0.0,25.181922340393065,22.677670383453368,17.839269415537515,4.389091474297261,11.042809576978906,27.122192367932612,59.23345909156199,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-13,25.09230613708496,26.08803367614746,24.89316177368164,24.89316177368164,11474,0.0,0.0,25.032563400268554,22.878060340881348,17.90440651575724,-0.5568811485979012,9.417332707778876,27.778937105493622,52.85459560730021,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-16,24.89316177368164,25.39102554321289,22.901708602905273,24.89316177368164,22560,0.0,0.0,25.032563400268554,23.080939626693727,17.974522256851195,-0.5568811485979012,8.455564656985288,28.409196622158696,52.85459560730021,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-17,24.89316177368164,25.09230613708496,23.100854873657227,23.89743423461914,24099,0.0,0.0,24.992734146118163,23.24274516105652,18.025138346354165,-4.382473342433977,7.529183721352204,28.94627888255674,48.52558690038886,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-18,23.89743423461914,24.096580505371094,21.905981063842773,22.30427360534668,62775,0.0,0.0,24.833418083190917,23.35600905418396,18.063307873408,-10.18443965052136,6.325605652830039,29.300841340182437,42.52427312817653,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-19,22.30427360534668,23.299999237060547,22.30427360534668,23.20042610168457,13375,0.0,0.0,24.79358901977539,23.492921447753908,18.11309418678284,-6.4257051160286265,5.536423279301582,29.70131555378727,46.53009802990677,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-20,23.20042610168457,23.20042610168457,20.11367416381836,20.511964797973633,24071,0.0,0.0,24.554614639282228,23.542707777023317,18.144625520706178,-16.46391075851463,4.298175349423864,29.750309534671775,37.978426499188586,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-23,20.910255432128906,21.208974838256836,20.711111068725586,21.208974838256836,4335,0.0,0.0,24.08662338256836,23.62485523223877,18.176571750640868,-11.947081575552408,1.9545861584770914,29.974208317945354,41.00566926460206,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-24,21.208974838256836,22.702564239501953,20.41239356994629,22.702564239501953,6818,0.0,0.0,23.718204689025878,23.741853094100954,18.225528303782145,-4.2821135192995845,-0.09960639964094126,30.26702270778107,46.97792086857316,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-25,22.901708602905273,22.901708602905273,20.81068229675293,20.81068229675293,16642,0.0,0.0,23.070982360839842,23.81030926704407,18.261208502451577,-9.797155702929643,-3.105070572214412,30.38736874313396,41.27771019469807,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-26,20.910255432128906,21.905981063842773,20.81068229675293,21.80640983581543,9411,0.0,0.0,22.622905349731447,23.903658628463745,18.306431086858115,-3.609154090925415,-5.357980126135238,30.575197945730597,45.056433824189725,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-27,22.802135467529297,22.802135467529297,21.30854606628418,21.408119201660156,18146,0.0,0.0,22.274401092529295,23.958423566818237,18.352483439445496,-3.8891366249110293,-7.0289368980906834,30.545948431827703,43.84117552235293,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-30,21.607263565063477,22.602991104125977,21.507692337036133,21.905981063842773,3403,0.0,0.0,21.97568302154541,24.021901082992553,18.39895066420237,-0.3171776623930196,-8.518135406426511,30.561256027118915,45.808764071192016,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-10-31,23.4991455078125,23.4991455078125,21.607263565063477,22.403846740722656,6182,0.0,0.0,21.826324272155762,24.084134006500243,18.449981649716694,2.645990508368144,-9.374676846321748,30.537441520274157,47.77913656914689,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-01,20.711111068725586,23.797863006591797,20.711111068725586,21.80640983581543,6809,0.0,0.0,21.776537895202637,24.08164472579956,18.501012635231017,0.13717488407270537,-9.572048989359006,30.163927783831053,45.634861195356144,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-02,21.80640983581543,22.901708602905273,21.408119201660156,21.80640983581543,7711,0.0,0.0,21.637136268615723,24.01692247390747,18.549969188372295,0.7823288863103135,-9.908789137647428,29.47149523548554,45.634861195356144,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-03,23.89743423461914,23.89743423461914,21.408119201660156,22.30427360534668,5463,0.0,0.0,21.816367149353027,23.942243003845213,18.60390437444051,2.236423931874109,-8.879184185670335,28.694721935568147,47.894872278114065,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-06,22.105127334594727,22.105127334594727,21.208974838256836,21.80640983581543,5517,0.0,0.0,21.876110649108888,23.892456674575804,18.652031151453652,-0.3186161123951788,-8.4392578499997,28.09573649416588,45.84255923216949,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-07,20.312820434570312,20.910255432128906,15.433759689331055,15.931623458862305,301011,0.0,0.0,21.199016571044922,23.723183155059814,18.652860919634502,-24.847346548033673,-10.640083868662979,27.182544582681977,29.680612168455085,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-08,16.429487228393555,16.429487228393555,14.836323738098145,15.931623458862305,52621,0.0,0.0,20.71111068725586,23.576313495635986,18.65452046394348,-23.07692378533089,-12.152887298985396,26.383916119450124,29.680612168455085,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-09,15.08525562286377,15.931623458862305,15.035470008850098,15.433759689331055,24840,0.0,0.0,20.073845672607423,23.397082710266112,18.655765120188395,-23.11508247574198,-14.203638457030918,25.414758170099844,28.68659997216426,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-10,15.433759689331055,15.533332824707031,14.537606239318848,15.533332824707031,51100,0.0,0.0,19.48636703491211,23.180512189865112,18.659913976987202,-20.286152894086182,-15.936425928362969,24.226254303492766,29.197322346349168,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-13,15.149999618530273,15.649999618530273,15.0,15.100000381469727,32435,0.0,0.0,18.805768966674805,22.93070454597473,18.660036849975587,-19.705488202965647,-17.988699697515486,22.88670558549691,28.24915940509389,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-14,15.100000381469727,15.5,14.899999618530273,15.0,63553,0.0,0.0,18.065384292602538,22.653503704071046,18.656007289886475,-16.968276140451437,-20.253464856493615,21.427395219509997,28.022997385736517,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-15,14.949999809265137,14.949999809265137,14.5,14.850000381469727,16251,0.0,0.0,17.36974334716797,22.389978075027464,18.647408652305604,-14.506506603674548,-22.421793853647344,20.070185045572657,27.665213032428426,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-16,14.899999618530273,15.149999618530273,14.5,15.149999618530273,34934,0.0,0.0,16.704102325439454,22.14639902114868,18.642969552675883,-9.303718790936555,-24.574183326653294,18.79222866600638,29.601131729463745,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-17,15.149999618530273,15.399999618530273,14.75,15.199999809265137,84671,0.0,0.0,15.993674945831298,21.884155440330506,18.637702457110088,-4.962431331474761,-26.9166452896034,17.418740269576148,29.937690220972854,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-20,15.199999809265137,15.199999809265137,14.75,14.899999618530273,21327,0.0,0.0,15.303033924102783,21.609433245658874,18.637403313318888,-2.6336888983675135,-29.18354798973261,15.946588064744391,29.040602223003717,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-21,14.75,14.949999809265137,14.149999618530273,14.149999618530273,22021,0.0,0.0,15.12487154006958,21.318450331687927,18.63126904964447,-6.445488934941543,-29.05266891004811,14.422964291285009,26.872640942917158,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-22,14.5,15.0,14.399999618530273,14.800000190734863,31348,0.0,0.0,15.011709213256836,21.02629222869873,18.622253743807473,-1.410292589034515,-28.605057658394973,12.909492685280801,31.635971374400796,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-23,14.800000190734863,14.949999809265137,14.600000381469727,14.649999618530273,26653,0.0,0.0,14.933333206176759,20.70300164222717,18.619456378618874,-1.8973231477168944,-27.868753216355962,11.190150889694488,31.13200475874531,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-24,14.949999809265137,15.550000190734863,14.699999809265137,14.899999618530273,26058,0.0,0.0,14.869999885559082,20.415832853317262,18.614178601900736,0.20174669268374024,-27.164372904126054,9.678935020170886,33.04637727857954,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-27,14.850000381469727,15.399999618530273,14.550000190734863,15.0,129830,0.0,0.0,14.859999847412109,20.16850380897522,18.61346813837687,0.942127550642422,-26.320762372074253,8.35435749553953,33.83862295526458,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-28,15.0,15.800000190734863,14.850000381469727,15.050000190734863,36698,0.0,0.0,14.864999866485595,19.937360644340515,18.61317434310913,1.244536333070321,-25.441485803161097,7.114242185786107,34.257500133271066,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-29,15.649999618530273,15.949999809265137,14.850000381469727,14.899999618530273,84823,0.0,0.0,14.86999979019165,19.712424778938292,18.609141222635905,0.20174733531879924,-24.56534415756159,5.9287182740080855,33.57082686710639,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-11-30,14.949999809265137,15.350000381469727,14.800000190734863,14.850000381469727,27585,0.0,0.0,14.839999866485595,19.49370687007904,18.60261701742808,0.06738891559370269,-23.87286848319463,4.790131688547544,33.330999930932805,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-01,15.25,16.299999237060547,14.949999809265137,15.449999809265137,89214,0.0,0.0,14.864999866485595,19.30741415023804,18.60565655231476,3.9354184193332786,-23.0088516731676,3.7717432650124496,38.96583335765409,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-04,15.449999809265137,15.800000190734863,14.699999809265137,15.550000190734863,18680,0.0,0.0,14.929999923706054,19.04894196987152,18.60745498339335,4.1527144688350885,-21.62294395499829,2.372634983517018,39.87790044275954,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-05,15.550000190734863,17.799999237060547,15.550000190734863,17.799999237060547,60827,0.0,0.0,15.294999885559083,18.834273171424865,18.624684325853984,16.37789715753174,-18.79166375921278,1.1253283110948558,55.86047610476782,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-06,17.799999237060547,18.25,16.75,17.350000381469727,47901,0.0,0.0,15.549999904632568,18.585950541496278,18.641067878405252,11.575565838433947,-16.33465358731821,-0.29567692832032044,52.83530062153622,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-07,17.350000381469727,17.899999618530273,16.649999618530273,17.350000381469727,26475,0.0,0.0,15.819999980926514,18.362521052360535,18.659110975265502,9.671304692717237,-13.846252724144186,-1.589517974881691,52.83530062153622,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-08,17.350000381469727,17.350000381469727,16.149999618530273,17.25,24653,0.0,0.0,16.055000019073486,18.171442008018495,18.68212914466858,7.443163995682614,-11.647077804893465,-2.7335596103392827,52.108006607952895,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-11,17.25,17.600000381469727,16.649999618530273,17.0,12204,0.0,0.0,16.255000019073485,17.974112963676454,18.707627725601196,4.583205044923643,-9.564382665654167,-3.9209394835291387,50.245879518640706,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-12,17.950000762939453,17.950000762939453,15.050000190734863,15.5,127789,0.0,0.0,16.3,17.764177107810973,18.720626306533813,-4.907975460122704,-8.242301903008881,-5.109066240957031,40.82014267439677,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-13,15.850000381469727,16.450000762939453,15.550000190734863,16.200000762939453,16400,0.0,0.0,16.43000011444092,17.611570286750794,18.725352104504903,-1.3998743146648602,-6.7090563366673335,-5.9479886494959855,45.91877093191586,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-14,16.299999237060547,16.700000762939453,15.600000381469727,15.699999809265137,20497,0.0,0.0,16.51500005722046,17.424059629440308,18.72757077217102,-4.93490914399966,-5.217266191421144,-6.960385618553993,43.064742518614175,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-15,15.800000190734863,15.800000190734863,15.100000381469727,15.100000381469727,50628,0.0,0.0,16.48000011444092,17.28876051902771,18.719395923614503,-8.373784729297066,-4.677954811721085,-7.642529761241098,39.86288876155803,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-18,15.100000381469727,15.600000381469727,14.649999618530273,15.449999809265137,17964,0.0,0.0,16.470000076293946,17.144786143302916,18.723680114746095,-6.193079916841921,-3.935809180521942,-8.432604924710816,42.54636839657968,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-19,15.75,16.75,15.149999618530273,15.75,19483,0.0,0.0,16.26500015258789,16.97097203731537,18.733368508021037,-3.166308931795188,-4.159878898952898,-9.407792677280995,44.81927717693092,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-20,16.350000381469727,16.450000762939453,15.25,16.450000762939453,9703,0.0,0.0,16.175000190734863,16.86195499897003,18.747645584742227,1.700158077043559,-4.073992655520244,-10.058279463672308,49.808745164578035,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-21,16.399999618530273,16.399999618530273,15.350000381469727,15.899999618530273,12082,0.0,0.0,16.030000114440917,16.714294743537902,18.755264886220296,-0.8109825014507006,-4.094068218831358,-10.88211846147754,46.26873700265026,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-22,15.25,16.5,15.050000190734863,15.949999809265137,22065,0.0,0.0,15.900000095367432,16.577841758728027,18.763300855954487,0.3144636075333913,-4.088841438022054,-11.647519346431572,46.64002170702081,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-27,15.949999809265137,16.200000762939453,15.399999618530273,15.75,19377,0.0,0.0,15.775000095367432,16.423942232131957,18.77132970492045,-0.15847920897809248,-3.9511959284350646,-12.505174165542376,45.29185764341991,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-28,15.699999809265137,16.049999237060547,15.5,15.75,2763,0.0,0.0,15.800000095367432,16.257596063613892,18.773965040842693,-0.3164562978837706,-2.8146594764437856,-13.403503051989546,45.29185764341991,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2023-12-29,15.899999618530273,15.899999618530273,15.25,15.550000190734863,18660,0.0,0.0,15.735000038146973,16.101185822486876,18.783646321296693,-1.1757219381227035,-2.274278356743693,-14.280829466898942,43.82275203467691,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-02,15.550000190734863,15.800000190734863,14.949999809265137,15.350000381469727,10923,0.0,0.0,15.700000095367432,15.939775586128235,18.788341840108234,-2.2292975272081654,-1.5042588866148767,-15.161349938284868,42.34362458388654,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-03,15.300000190734863,16.0,15.050000190734863,16.0,9653,0.0,0.0,15.790000057220459,15.782168745994568,18.79306050936381,1.3299553009406895,0.04962126151311305,-16.021295530172093,48.43517322567356,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-04,15.949999809265137,16.149999618530273,15.449999809265137,16.049999237060547,16850,0.0,0.0,15.85,15.638258481025696,18.804419128100076,1.2618248394987206,1.3539967972214744,-16.83732225657042,48.88256132068825,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-05,16.399999618530273,16.5,15.600000381469727,16.100000381469727,16882,0.0,0.0,15.885000038146973,15.642467904090882,18.819928399721782,1.35348028206762,1.5504723138518528,-16.883488758001185,49.35578012749499,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-08,16.5,16.5,16.100000381469727,16.450000762939453,11740,0.0,0.0,15.885000038146973,15.65542733669281,18.8366947889328,3.5568191591794833,1.466409677084294,-16.888671223303426,52.65947008435922,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-09,16.600000381469727,16.899999618530273,16.399999618530273,16.399999618530273,7656,0.0,0.0,15.935000038146972,15.67958333492279,18.85304450194041,2.9181021604652244,1.628976343110454,-16.832619085426746,52.13622508016316,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-10,16.899999618530273,16.899999618530273,16.0,16.75,7523,0.0,0.0,16.01500005722046,15.710000014305114,18.871066228548685,4.589447019378327,1.9414388455609093,-16.75086174760714,55.471559233257224,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-11,16.700000762939453,16.700000762939453,15.5,15.649999618530273,15600,0.0,0.0,16.005000019073485,15.723749995231628,18.87867662906647,-2.2180593572018137,1.7886955969609548,-16.711587871457958,44.88524059133365,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-12,15.649999618530273,16.700000762939453,15.25,15.800000190734863,6457,0.0,0.0,16.010000038146973,15.74375,18.890856122970582,-1.3116792436711064,1.691147522966085,-16.65941502324936,46.3877708167248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-15,15.5,15.850000381469727,15.0,15.850000381469727,5480,0.0,0.0,16.04000005722046,15.76875,18.90303740501404,-1.1845366276367615,1.720174758433355,-16.580866544667934,46.907351646468015,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-16,15.75,15.850000381469727,15.149999618530273,15.850000381469727,10684,0.0,0.0,16.090000057220458,15.786250019073487,18.914803791046143,-1.4916076749361482,1.924143085153027,-16.540239098084886,46.90735164646801,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-17,15.25,16.350000381469727,15.149999618530273,15.149999618530273,12294,0.0,0.0,16.005000019073485,15.785000014305115,18.91741775671641,-5.342083096059294,1.3937282519416851,-16.558379069993137,40.529724515508825,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-18,15.949999809265137,16.450000762939453,15.0,15.050000190734863,16163,0.0,0.0,15.905000114440918,15.78875002861023,18.917953729629517,-5.3756675105570055,0.7362842886234602,-16.540920575983293,39.69932887446963,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-19,15.850000381469727,15.850000381469727,15.100000381469727,15.550000190734863,8851,0.0,0.0,15.850000095367431,15.823750042915345,18.921826601028442,-1.892743866419599,0.16589021174433355,-16.373031121343807,45.69090581986282,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-22,15.199999809265137,16.200000762939453,14.649999618530273,15.100000381469727,14300,0.0,0.0,15.71500005722046,15.831250047683715,18.925268562634788,-3.9134564015999684,-0.7343070832253374,-16.348610878155593,41.67720843083292,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-23,16.100000381469727,16.100000381469727,14.899999618530273,15.199999809265137,1617,0.0,0.0,15.595000076293946,15.845000052452088,18.931618277231852,-2.532864797027168,-1.5777846344623587,-16.304037930512745,42.878055519026304,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-24,15.399999618530273,15.399999618530273,14.850000381469727,15.050000190734863,6332,0.0,0.0,15.425000095367432,15.848750066757201,18.937132891019186,-2.43111768112852,-2.673712246106942,-16.308608288462874,41.497823652119784,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-25,15.050000190734863,15.399999618530273,14.649999618530273,15.050000190734863,3981,0.0,0.0,15.365000152587891,15.850000071525574,18.942232608795166,-2.0501136265851128,-3.059936383274741,-16.324541046095174,41.49782365211978,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-26,15.100000381469727,15.199999809265137,14.75,15.100000381469727,15685,0.0,0.0,15.295000171661377,15.851250076293946,18.948993651072183,-1.2749250604975229,-3.509186354106284,-16.347799950858914,42.2168896557409,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-29,15.0,15.0,14.600000381469727,14.649999618530273,16600,0.0,0.0,15.175000095367432,15.845000076293946,18.956153559684754,-3.4596406822918486,-4.228463096878842,-16.412366958281527,37.72293689122429,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-30,15.0,15.899999618530273,14.649999618530273,15.899999618530273,5977,0.0,0.0,15.180000019073486,15.87125005722046,18.97580455938975,4.74308035936836,-4.355359758398468,-16.36059484304223,52.76448063631489,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-01-31,15.899999618530273,15.899999618530273,14.699999809265137,15.600000381469727,11869,0.0,0.0,15.225000095367431,15.875000071525573,18.98424295584361,2.463056050925073,-4.094488020343534,-16.37801882092416,49.66418962306487,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-01,15.0,15.699999809265137,15.0,15.699999809265137,5375,0.0,0.0,15.290000057220459,15.87875006198883,18.96986618041992,2.6814895389818014,-3.7077855780206797,-16.294875720428855,50.70395398565831,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-02,15.0,16.0,15.0,15.75,17468,0.0,0.0,15.310000038146972,15.827500081062317,18.9525869846344,2.8739383458961933,-3.269625905954255,-16.488972751349003,51.24623555893032,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-05,14.949999809265137,16.0,14.949999809265137,15.550000190734863,6415,0.0,0.0,15.355000019073486,15.782500076293946,18.939864404996236,1.2699457598121395,-2.708696690346194,-16.670469551352195,48.92771832539184,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-06,15.149999618530273,15.649999618530273,15.149999618530273,15.600000381469727,2017,0.0,0.0,15.395000076293945,15.738750076293945,18.926313837369282,1.3316031449162002,-2.1840997432049187,-16.841968216661474,49.54233211033843,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-07,15.600000381469727,15.600000381469727,14.600000381469727,15.149999618530273,13749,0.0,0.0,15.405000019073487,15.686250066757202,18.91191747188568,-1.6553093166341344,-1.792971847871715,-17.056268408128005,44.36737192486062,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-08,14.699999809265137,14.949999809265137,14.550000190734863,14.600000381469727,18720,0.0,0.0,15.360000038146973,15.626250076293946,18.893767555554707,-4.947914419204212,-1.7038639267068425,-17.294155173937877,39.00470217034624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-09,14.600000381469727,14.800000190734863,13.850000381469727,14.699999809265137,11955,0.0,0.0,15.319999980926514,15.606250071525574,18.87105744679769,-4.046998514577554,-1.8342016133737218,-17.30060641528138,40.41488442698282,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-12,14.149999618530273,14.550000190734863,14.050000190734863,14.149999618530273,19381,0.0,0.0,15.269999980926514,15.555000042915344,18.840859794616698,-7.334645473446057,-1.832208686612225,-17.440073263748854,35.54708287366215,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-13,14.149999618530273,14.199999809265137,13.800000190734863,14.0,16516,0.0,0.0,15.080000019073486,15.512500047683716,18.809827041625976,-7.161803830951461,-2.7880743096262526,-17.529810277602795,34.332549166741245,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-14,14.0,14.199999809265137,14.0,14.100000381469727,2558,0.0,0.0,14.930000019073486,15.487500047683715,18.77298944791158,-5.559274189842007,-3.5996773326474254,-17.501151904143654,35.904819309328715,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-15,14.199999809265137,14.199999809265137,13.800000190734863,14.149999618530273,3094,0.0,0.0,14.775,15.455000042915344,18.74154713948568,-4.230121025175817,-4.399870857503229,-17.53615681837741,36.72062289404385,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-16,14.149999618530273,14.149999618530273,13.550000190734863,14.0,16520,0.0,0.0,14.6,15.411250042915345,18.708025058110554,-4.109589041095888,-5.264011943588459,-17.622250370922753,35.2702482134341,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-19,13.899999618530273,13.899999618530273,13.199999809265137,13.699999809265137,16409,0.0,0.0,14.414999961853027,15.342500019073487,18.671588095029197,-4.960112067152433,-6.045299371467559,-17.82969964318134,32.50498662295139,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-20,13.699999809265137,13.850000381469727,13.199999809265137,13.800000190734863,6233,0.0,0.0,14.234999942779542,15.2900000333786,18.635984468460084,-3.0558465317404133,-6.899935175251517,-17.954428115908204,34.35259564244589,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-21,13.800000190734863,13.949999809265137,13.100000381469727,13.949999809265137,26476,0.0,0.0,14.114999961853027,15.240000033378601,18.592088452974956,-1.168970265914394,-7.381890216939653,-18.02964969790675,37.1325484472434,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-22,13.5,13.699999809265137,13.050000190734863,13.550000190734863,11318,0.0,0.0,14.00999994277954,15.185000038146972,18.543614451090495,-3.283367265691898,-7.7378998512720285,-18.111972840041506,33.106431869872054,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-23,13.5,13.949999809265137,13.100000381469727,13.300000190734863,16184,0.0,0.0,13.869999980926513,15.123750042915344,18.488493371009827,-4.109587534069875,-8.28994170381799,-18.199121261932792,30.85469343851254,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-26,13.300000190734863,13.699999809265137,13.050000190734863,13.399999618530273,10838,0.0,0.0,13.794999980926514,15.07000002861023,18.417610192298888,-2.8633589194808478,-8.460517884957808,-18.176137559304102,32.82289264741128,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-27,13.399999618530273,14.75,13.199999809265137,14.5,15523,0.0,0.0,13.844999980926513,15.048750019073486,18.335149359703063,4.730949945654346,-7.9990034828227214,-17.924039101925267,49.76282175006221,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-28,14.550000190734863,14.550000190734863,12.649999618530273,13.5,42040,0.0,0.0,13.78499994277954,14.986250019073486,18.236887256304424,-2.0674642289630265,-8.01568153984536,-17.824517920991177,39.90994107230953,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-02-29,13.5,13.5,11.699999809265137,12.600000381469727,68508,0.0,0.0,13.630000019073487,14.900000047683715,18.143571734428406,-7.556857198550286,-8.523490097623569,-17.87725004878636,33.48417592681645,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-01,13.300000190734863,13.449999809265137,12.600000381469727,13.199999809265137,15451,0.0,0.0,13.55,14.827500033378602,18.064383697509765,-2.583027237895675,-8.615747971693036,-17.91859450249265,40.37633971964012,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-04,13.149999618530273,13.149999618530273,12.149999618530273,12.449999809265137,20310,0.0,0.0,13.425,14.727500009536744,17.98641361395518,-7.262571253146099,-8.843999380025894,-18.11875159976267,35.43386705620624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-05,12.399999618530273,12.75,12.0,12.0,9853,0.0,0.0,13.244999980926513,14.617500019073486,17.89805535475413,-9.399773368964725,-9.38943072588391,-18.329116044493936,32.8366296196762,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-06,12.0,12.399999618530273,11.199999809265137,11.75,35942,0.0,0.0,13.025,14.492500019073486,17.794337407747904,-9.788867562380041,-10.12592732200875,-18.55555120156793,31.45712094067322,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-07,11.600000381469727,11.699999809265137,11.25,11.600000381469727,19779,0.0,0.0,12.830000019073486,14.391250038146973,17.68190152645111,-9.58690285093689,-10.848606027517222,-18.610280593303337,30.625763819760138,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-08,11.649999618530273,12.5,10.600000381469727,11.850000381469727,54296,0.0,0.0,12.685000038146972,14.292500042915345,17.563251248995464,-6.582575121530884,-11.24715759973144,-18.622697812098945,33.76753191662951,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-11,11.850000381469727,11.850000381469727,10.899999618530273,11.149999618530273,48788,0.0,0.0,12.460000038146973,14.175000023841857,17.44457603295644,-10.513646995233236,-12.09876531083114,-18.742651027675723,29.71033039003069,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-12,11.149999618530273,11.800000190734863,10.550000190734863,10.699999809265137,62107,0.0,0.0,12.080000019073486,14.046250009536744,17.32629968325297,-11.423842778389274,-13.998398071572598,-18.931045483916073,27.428769392721776,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-13,10.649999618530273,11.0,9.399999618530273,10.699999809265137,162713,0.0,0.0,11.8,13.935000014305114,17.201385156313577,-9.322035514702238,-15.321133922593525,-18.989082055462102,27.428769392721776,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-14,10.199999809265137,10.550000190734863,9.899999618530273,10.050000190734863,64719,0.0,0.0,11.544999980926514,13.810000014305114,17.06939442952474,-12.949326917813242,-16.401158805448194,-19.094962206637433,24.302376936255584,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-15,10.699999809265137,10.699999809265137,9.5,10.399999618530273,24218,0.0,0.0,11.264999961853027,13.68125,16.941150124867757,-7.678653761668243,-17.661032713728446,-19.24249593941429,28.995500182214684,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-18,10.399999618530273,10.699999809265137,9.699999809265137,9.960000038146973,28635,0.0,0.0,11.01599998474121,13.552749991416931,16.803430755933125,-9.586056173356514,-18.717603499527886,-19.345339720987695,26.750190700044953,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-19,9.800000190734863,10.199999809265137,9.399999618530273,9.899999618530273,25628,0.0,0.0,10.805999946594238,13.42024998664856,16.65608389377594,-8.384234060166836,-19.479890781879387,-19.427339149849914,26.449411138605967,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-20,9.899999618530273,10.699999809265137,9.899999618530273,10.350000381469727,25839,0.0,0.0,10.66599998474121,13.302749991416931,16.522444303830465,-2.9626814524990936,-19.821089687297576,-19.486791743441366,32.57290819851559,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-21,10.350000381469727,10.949999809265137,9.899999618530273,10.949999809265137,14262,0.0,0.0,10.600999927520752,13.200249981880187,16.40625128746033,3.2921411577257267,-19.690915383628287,-19.5413397576725,39.77283453336267,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-22,10.899999618530273,10.899999618530273,10.050000190734863,10.550000190734863,18506,0.0,0.0,10.470999908447265,13.086499977111817,16.291703565915427,0.7544674145576729,-19.986245927016704,-19.673839361460967,36.94083149175224,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-25,10.050000190734863,10.399999618530273,10.050000190734863,10.149999618530273,7032,0.0,0.0,10.370999908447265,12.973999977111816,16.17714161078135,-2.130944864216856,-20.063203894378404,-19.80041784102812,34.3098842249495,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-26,10.050000190734863,10.699999809265137,10.050000190734863,10.199999809265137,10647,0.0,0.0,10.320999908447266,12.831499981880189,16.06548563639323,-1.1723679900732928,-19.56513328120709,-20.130021137904954,34.93370137558887,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-27,10.199999809265137,10.449999809265137,9.600000381469727,10.449999809265137,35889,0.0,0.0,10.295999908447266,12.702749967575073,15.961721396446228,1.4957255457191956,-18.946685286817864,-20.41741832179042,38.098953477226814,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-03-28,10.5,12.300000190734863,10.199999809265137,12.300000190734863,28276,0.0,0.0,10.520999908447266,12.617749977111817,15.84848066965739,16.90904189495569,-16.617464068221253,-20.38511299528508,55.39228518807903,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-02,12.199999809265137,12.199999809265137,10.399999618530273,10.399999618530273,25181,0.0,0.0,10.520999908447266,12.483999967575073,15.715257740020752,-1.1500835564102758,-15.724127396878758,-20.561277618863993,42.31674747858191,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-03,10.850000381469727,10.850000381469727,9.619999885559082,10.300000190734863,61586,0.0,0.0,10.554999923706054,12.352749967575074,15.573733528455099,-2.41591411477392,-14.553439910853546,-20.68215405763106,41.75804715574137,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-04,10.300000190734863,12.949999809265137,10.050000190734863,11.199999809265137,64644,0.0,0.0,10.684999942779541,12.242749953269959,15.448007027308146,4.819839674717175,-12.723857110831158,-20.74867695471725,48.36552751317604,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-05,12.100000381469727,12.899999618530273,11.199999809265137,12.899999618530273,162560,0.0,0.0,10.939999866485596,12.186499953269958,15.348064009348551,17.915902888162595,-10.228532323178595,-20.599106533259665,58.04723165279957,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-08,12.899999618530273,12.899999618530273,12.0,12.449999809265137,16328,0.0,0.0,11.089999866485595,12.132749938964844,15.244370992978414,12.263299902189482,-8.594507244647092,-20.41160671992822,55.101947815909526,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-09,12.300000190734863,12.399999618530273,11.850000381469727,12.100000381469727,7564,0.0,0.0,11.244999885559082,12.067749953269958,15.146059044202168,7.603383767114511,-6.817758661695988,-20.324158792386132,52.85560329882837,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-10,12.100000381469727,12.5,11.850000381469727,12.199999809265137,25252,0.0,0.0,11.449999904632568,12.01899995803833,15.061856762568157,6.550217562265004,-4.734171356953987,-20.202401685906068,53.439640620253925,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-11,12.149999618530273,12.600000381469727,11.649999618530273,11.949999809265137,10508,0.0,0.0,11.624999904632569,11.967749953269958,14.968103210131327,2.7956981273011055,-2.863947274765211,-20.044979746201548,51.71478626671173,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-12,11.699999809265137,12.699999809265137,11.600000381469727,11.850000381469727,11809,0.0,0.0,11.764999961853027,11.911499953269958,14.895920173327129,0.7224855069469267,-1.229903807175131,-20.035151808890067,51.005618305926546,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-15,11.449999809265137,11.949999809265137,11.0,11.399999618530273,8962,0.0,0.0,11.674999904632568,11.842749953269958,14.81417871316274,-2.355462855234592,-1.4164788524566676,-20.058005357074556,47.827208963492694,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-16,11.199999809265137,11.199999809265137,10.899999618530273,11.149999618530273,9565,0.0,0.0,11.749999904632569,11.771499943733215,14.71790734132131,-5.106385455081906,-0.1826448558247827,-20.01920061907102,46.10818747996065,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-17,11.699999809265137,11.699999809265137,10.5,10.949999809265137,14768,0.0,0.0,11.814999866485596,11.702749943733215,14.63573498725891,-7.321202429075916,0.9591756065205077,-20.03988898459145,44.72330038602332,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-18,11.25,11.25,10.0,10.0,16784,0.0,0.0,11.694999885559081,11.607749938964844,14.537348238627116,-14.493372399704402,0.7516525343241358,-20.152219315198426,38.76699357979846,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-19,10.0,10.449999809265137,9.920000076293945,10.050000190734863,60158,0.0,0.0,11.40999994277954,11.510249948501587,14.442697246869406,-11.919366861218176,-0.8709628910803673,-20.304014189617217,39.22576414748148,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-22,10.350000381469727,10.350000381469727,9.600000381469727,9.619999885559082,42993,0.0,0.0,11.126999950408935,11.411999940872192,14.340314070383707,-13.543633248551137,-2.4973711175946196,-20.420153388127023,36.68053212508338,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-23,9.600000381469727,9.680000305175781,9.479999542236328,9.539999961853027,37409,0.0,0.0,10.870999908447265,11.317999935150146,14.23311534722646,-12.243583458776316,-3.9494612940811162,-20.48121820810206,36.209785291040454,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-24,9.5,9.680000305175781,9.460000038146973,9.680000305175781,41556,0.0,0.0,10.61899995803833,11.224999952316285,14.13206193447113,-8.842637315877832,-5.398663669062255,-20.5706852661316,37.71622216865757,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-25,9.760000228881836,12.5,9.539999961853027,10.199999809265137,49147,0.0,0.0,10.44399995803833,11.117499947547913,14.035341850916545,-2.3362710623662486,-6.058016574653829,-20.78924713314403,43.09185747215199,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-26,10.25,10.649999618530273,9.319999694824219,10.350000381469727,40698,0.0,0.0,10.29399995803833,11.038749957084656,13.935722907384237,0.5440103328120419,-6.746687821915431,-20.788106720782586,44.57783755066324,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-29,10.300000190734863,10.600000381469727,9.760000228881836,10.050000190734863,26204,0.0,0.0,10.159000015258789,10.974999952316285,13.837752827008565,-1.0729385211163303,-7.43507918544709,-20.687989664801286,42.2042354776568,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-04-30,10.050000190734863,11.0,9.960000038146973,10.199999809265137,2074,0.0,0.0,10.064000034332276,10.899999952316284,13.789989296595255,1.3513491103826716,-7.66972405175429,-20.957154368441092,43.81511016105419,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-02,10.199999809265137,10.699999809265137,10.050000190734863,10.149999618530273,13590,0.0,0.0,9.98400001525879,10.842499947547912,13.741809097925822,1.6626562802261862,-7.917915023677511,-21.09845312008831,43.381067747048064,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-03,10.199999809265137,11.399999618530273,10.149999618530273,10.5,30096,0.0,0.0,10.034000015258789,10.804999947547913,13.700694433848064,4.644209527930648,-7.135584785116955,-21.135384781272347,47.31542070531229,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-06,10.199999809265137,10.75,10.100000381469727,10.699999809265137,5637,0.0,0.0,10.098999977111816,10.778749942779541,13.660416658719381,5.95108261724344,-6.306389602470321,-21.0950133362183,49.47592799656168,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-07,10.699999809265137,10.699999809265137,10.0,10.350000381469727,13846,0.0,0.0,10.17200002670288,10.747499942779541,13.620833325386048,1.7499051740028606,-5.35473290663562,-21.095136501312922,45.92650276732357,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-08,10.0,10.600000381469727,10.0,10.600000381469727,10618,0.0,0.0,10.27800006866455,10.716249942779541,13.584166661898296,3.132908256995321,-4.089582423469673,-21.112202098954395,48.754488864575166,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-10,10.5,10.949999809265137,10.100000381469727,10.649999618530273,17338,0.0,0.0,10.375,10.703749942779542,13.549166655540466,2.650598732821913,-3.071352979441635,-21.000676905818327,49.325299497107856,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-13,10.600000381469727,10.899999618530273,10.149999618530273,10.899999618530273,15016,0.0,0.0,10.444999980926514,10.70874993801117,13.5137499888738,4.356147806937561,-2.4629387987524476,-20.756637152323037,52.19272117347689,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-14,11.850000381469727,11.850000381469727,10.149999618530273,10.300000190734863,8720,0.0,0.0,10.439999961853028,10.698749947547913,13.472916658719381,-1.3409939811275193,-2.4185067130594025,-20.590691543958204,45.53345345905746,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-15,10.300000190734863,10.300000190734863,9.619999885559082,9.800000190734863,22696,0.0,0.0,10.414999961853027,10.692499947547912,13.430416663487753,-5.904942615177349,-2.5952769423068647,-20.38594024698583,40.855354842268625,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-16,10.050000190734863,10.399999618530273,10.050000190734863,10.050000190734863,4046,0.0,0.0,10.4,10.683749961853028,13.396250001589458,-3.3653827813955486,-2.655902308329697,-20.248204082594704,43.95580061262936,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-17,10.050000190734863,11.449999809265137,10.050000190734863,10.25,3524,0.0,0.0,10.410000038146972,10.690999960899353,13.358333333333333,-1.5369840303617588,-2.6283782974473264,-19.967561116162045,46.37755223849636,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-20,10.25,10.449999809265137,10.100000381469727,10.199999809265137,4590,0.0,0.0,10.380000019073487,10.698499965667725,13.321250001589457,-1.734106064331363,-2.977052368241608,-19.688467941137596,45.844204892564576,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-21,10.100000381469727,10.399999618530273,9.819999694824219,10.399999618530273,7699,0.0,0.0,10.35,10.699749946594238,13.283750001589457,0.4830881017417758,-3.2687674790527708,-19.452338795039292,48.40038460343909,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-22,9.5,10.550000190734863,9.5,10.0,16776,0.0,0.0,10.314999961853028,10.67599995136261,13.24208333492279,-3.0538047796215393,-3.3814161779150806,-19.378245240254284,43.93394628562882,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-23,10.0,10.449999809265137,9.800000190734863,10.149999618530273,8594,0.0,0.0,10.269999885559082,10.665999937057496,13.201249996821085,-1.1684544144693174,-3.7127325504903457,-19.20462123188401,45.94830631732502,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-24,10.350000381469727,11.449999809265137,10.050000190734863,11.399999618530273,20019,0.0,0.0,10.344999885559082,10.697249937057496,13.172083330154418,10.198160895524994,-3.292902882245902,-18.78847355475931,59.127133098386295,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-27,11.399999618530273,11.699999809265137,11.100000381469727,11.550000190734863,10532,0.0,0.0,10.40999994277954,10.730999946594238,13.144583328564961,10.951011087622877,-2.9913335701448336,-18.361809740485867,60.375657675864886,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-28,12.350000381469727,13.5,11.550000190734863,12.649999618530273,58738,0.0,0.0,10.644999885559082,10.785999941825867,13.121249993642172,18.83513155966452,-1.3072506677847837,-17.797466346177664,68.07676415539598,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-29,13.75,13.75,12.25,13.149999618530273,24397,0.0,0.0,10.979999828338624,10.807249927520752,13.1012499888738,19.76320422693477,1.5984630870612364,-17.509780084352414,70.85002941056233,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-30,13.350000381469727,14.850000381469727,13.0,13.449999809265137,62330,0.0,0.0,11.31999979019165,10.883499932289123,13.064999993642171,18.816254934201066,4.010657055342291,-16.697283294409747,72.39934571545126,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-05-31,13.5,13.699999809265137,12.699999809265137,12.949999809265137,18123,0.0,0.0,11.589999771118164,10.94974992275238,13.028333322207134,11.734254227821825,5.847164116829871,-15.954330826889072,66.09415560234363,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-03,13.0,13.5,12.800000190734863,13.149999618530273,43677,0.0,0.0,11.884999752044678,10.99849991798401,12.993333315849304,10.643667588364627,8.060188577272461,-15.352745514747868,67.32014829624798,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-04,12.75,14.800000190734863,12.75,13.899999618530273,27286,0.0,0.0,12.234999752044677,11.023499917984008,12.965416646003723,13.608499388872861,10.990155967472715,-14.977665439068351,71.48419271662634,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-05,14.0,15.199999809265137,13.899999618530273,14.800000190734863,57401,0.0,0.0,12.714999771118164,11.082249927520753,12.947083314259848,16.39795876640699,14.733017701962972,-14.40350186582315,75.5158731668562,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-07,14.800000190734863,15.399999618530273,14.600000381469727,15.399999618530273,9558,0.0,0.0,13.239999771118164,11.164749908447266,12.9462499777476,16.31419852531984,18.58751767561547,-13.760742086414437,77.77214169409103,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-10,15.300000190734863,15.300000190734863,14.100000381469727,14.850000381469727,22451,0.0,0.0,13.58499984741211,11.23099992275238,12.934999974568685,9.311744926508734,20.959842764230345,-13.17356053472373,71.2870962470098,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-11,14.850000381469727,15.600000381469727,14.850000381469727,15.399999618530273,13407,0.0,0.0,13.96999979019165,11.31724991798401,12.932499972979228,10.236219397387732,23.439880637364126,-12.489851601547056,73.65303872532121,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-12,14.850000381469727,15.350000381469727,14.850000381469727,15.050000190734863,10139,0.0,0.0,14.20999984741211,11.397249913215637,12.932083304723104,5.911332528801765,24.67919854012291,-11.868415593540984,69.71617357034862,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-13,14.600000381469727,16.0,14.600000381469727,15.649999618530273,11877,0.0,0.0,14.45999984741211,11.503499913215638,12.933749969800314,8.229597397479477,25.700873269012135,-11.058278224986882,72.43616592012648,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-14,15.649999618530273,15.699999809265137,15.050000190734863,15.25,7670,0.0,0.0,14.639999866485596,11.60599992275238,12.929583303133647,4.1666676166496295,26.14165055942632,-10.23686030206774,68.04816436466021,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-17,15.75,15.75,14.5,15.25,27455,0.0,0.0,14.869999885559082,11.713499927520752,12.919583296775818,2.555481623170374,26.947538972721247,-9.335311685757333,68.04816436466021,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-18,15.0,15.149999618530273,14.5,14.550000190734863,16583,0.0,0.0,15.00999994277954,11.827249932289124,12.90833330154419,-3.064621944025768,26.910313291015452,-8.37508099613246,60.597824840326425,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-19,14.100000381469727,14.100000381469727,13.350000381469727,13.600000381469727,24718,0.0,0.0,14.980000019073486,11.915999937057496,12.888749972979229,-9.21228061312855,25.713327443778134,-7.547279898834766,52.23867545164572,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-20,13.600000381469727,13.949999809265137,13.050000190734863,13.949999809265137,9513,0.0,0.0,14.894999980926514,12.024249935150147,12.87374997138977,-6.344412036733653,23.874670447296552,-6.598699198970981,54.71705715294221,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-24,12.600000381469727,15.399999618530273,12.600000381469727,14.199999809265137,17583,0.0,0.0,14.775,12.14074993133545,12.860833303133647,-3.891710258780803,21.697589387501623,-5.599041328237604,56.455200091755756,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-25,14.800000190734863,15.5,14.199999809265137,14.399999618530273,3440,0.0,0.0,14.729999923706055,12.25874991416931,12.851249965031942,-2.24032794898178,20.159070270944536,-4.610446862949632,57.84910113139847,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-26,14.399999618530273,14.399999618530273,13.25,14.350000381469727,14050,0.0,0.0,14.625,12.362499928474426,12.842916631698609,-1.8803392720018697,18.301315143504105,-3.740713398687248,57.354808703315385,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-27,14.0,14.350000381469727,13.25,13.550000190734863,27520,0.0,0.0,14.475,12.442499923706055,12.822499966621399,-6.39032683430146,16.335142364932036,-2.963540993601339,49.99413157969883,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-06-28,15.449999809265137,15.449999809265137,12.899999618530273,13.600000381469727,31906,0.0,0.0,14.270000076293945,12.531249928474427,12.802083309491476,-4.695162517463866,13.875312979502564,-2.115541466725596,50.42238399936298,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-01,14.0,14.949999809265137,13.75,14.649999618530273,10377,0.0,0.0,14.210000038146973,12.642499923706055,12.789999969800313,3.0964080169043973,12.398656309276978,-1.1532450855553913,58.46651649627795,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-02,14.649999618530273,14.75,13.850000381469727,14.649999618530273,14124,0.0,0.0,14.15,12.754999923706055,12.77499996026357,3.533566208694509,10.936888158668195,-0.15655605964558678,58.46651649627795,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-03,14.600000381469727,14.949999809265137,13.75,14.949999809265137,15420,0.0,0.0,14.189999961853028,12.866249918937683,12.762916628519694,5.355883364730206,10.288546011895294,0.809636961719889,60.58561083120664,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-04,15.0,15.5,14.949999809265137,15.5,11908,0.0,0.0,14.379999923706055,12.986249923706055,12.752499961853028,7.788595843088815,10.732505597753415,1.8329736330307858,64.1926443273782,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-05,15.850000381469727,16.450000762939453,15.0,15.449999809265137,3960,0.0,0.0,14.529999923706054,13.11374990940094,12.750833296775818,6.331726706055106,10.799733288262853,2.8462187856921455,63.62261084439734,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-08,15.449999809265137,15.449999809265137,15.0,15.399999618530273,19030,0.0,0.0,14.649999904632569,13.233749890327454,12.747499958674114,5.1194520053241925,10.70180429615231,3.8144729023707,63.01994331703914,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-09,15.399999618530273,15.550000190734863,14.699999809265137,15.550000190734863,18029,0.0,0.0,14.764999961853027,13.356249904632568,12.744999957084655,5.316628722722446,10.547496994136349,4.795998035356077,64.11805918749394,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-10,15.550000190734863,16.399999618530273,15.0,16.299999237060547,25330,0.0,0.0,14.95999984741211,13.491249895095825,12.748749947547912,8.957215262807905,10.886685546090042,5.824100014532991,69.06447444398745,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-11,16.0,17.75,16.0,17.299999237060547,22939,0.0,0.0,15.334999752044677,13.666249871253967,12.766666611035665,12.813821433246966,12.210737375004479,7.046344105521568,74.17611393462107,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-12,17.399999618530273,18.350000381469727,16.850000381469727,17.350000381469727,26965,0.0,0.0,15.709999752044677,13.854999876022339,12.785833279291788,10.439214865115458,13.388667575758179,8.362119021700336,74.40385529092956,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-15,17.350000381469727,17.399999618530273,16.5,17.200000762939453,17169,0.0,0.0,15.964999866485595,14.033749890327453,12.79958328406016,7.735677461835904,13.76146782756351,9.642240523597751,72.34270369410243,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-16,16.950000762939453,17.049999237060547,16.100000381469727,17.049999237060547,5818,0.0,0.0,16.20499982833862,14.203749871253967,12.815833274523417,5.214436394156733,14.089588842555251,10.829702345532134,70.24698779701338,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-17,17.049999237060547,17.5,17.049999237060547,17.25,12099,0.0,0.0,16.434999847412108,14.379999876022339,12.832916609446208,4.958930089167137,14.29068142633534,12.055585753883378,71.43518820655504,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-18,16.799999237060547,17.350000381469727,16.799999237060547,17.299999237060547,14755,0.0,0.0,16.614999771118164,14.552499866485595,12.851666601498922,4.1227774624054865,14.172822013779953,13.234340087754076,71.73904018837925,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-19,17.25,17.25,16.149999618530273,16.700000762939453,19059,0.0,0.0,16.739999866485597,14.719999885559082,12.865416606267294,-0.2389432727907269,13.72282606406959,14.415260197546505,63.06905278178554,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-22,16.75,17.399999618530273,16.049999237060547,17.350000381469727,14302,0.0,0.0,16.93499994277954,14.899999904632569,12.884166606267293,2.4505488047971706,13.657718464241524,15.64581831303475,67.6327456083248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-23,16.200000762939453,17.799999237060547,16.200000762939453,17.399999618530273,20152,0.0,0.0,17.119999885559082,15.049999904632568,12.90708327293396,1.6355124698766759,13.754152784342171,16.60264047565483,67.96072278848087,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-24,17.5,18.799999237060547,17.5,18.200000762939453,38670,0.0,0.0,17.310000038146974,15.216249918937683,12.92624994913737,5.141540859798595,13.759961425209463,17.715888048050125,72.72329512833248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-25,17.950000762939453,18.700000762939453,17.950000762939453,18.700000762939453,26516,0.0,0.0,17.450000190734862,15.367499947547913,12.952083285649618,7.163326983046588,13.551327478736965,18.648866044387457,75.20415309542888,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-26,18.700000762939453,19.5,18.600000381469727,19.25,32877,0.0,0.0,17.64000015258789,15.519999957084655,12.981666620572408,9.126983183024022,13.65979511189036,19.553216167866147,77.61587327950178,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-29,19.200000762939453,19.25,18.049999237060547,19.200000762939453,33601,0.0,0.0,17.84000015258789,15.663749980926514,13.010416626930237,7.623321741700094,13.89354512368596,20.39391535321127,76.8837762382083,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-30,19.200000762939453,19.350000381469727,18.700000762939453,19.350000381469727,14726,0.0,0.0,18.07000026702881,15.823749995231628,13.04208329518636,7.083564446739119,14.195435800452314,21.328392382464997,77.56738782033582,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-07-31,19.399999618530273,20.799999237060547,19.350000381469727,19.899999618530273,46850,0.0,0.0,18.335000228881835,15.99249999523163,13.077916622161865,8.535584238407615,14.647492476777572,22.2862972541873,79.91303873754201,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-01,19.950000762939453,19.950000762939453,19.0,19.399999618530273,15335,0.0,0.0,18.545000267028808,16.12999999523163,13.113333288828532,4.610403554544944,14.972103363367047,23.004575876776087,72.4919765018551,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-02,19.25,19.75,17.049999237060547,19.75,19591,0.0,0.0,18.850000190734864,16.253749990463255,13.156249952316283,4.774534748851107,15.973238186848793,23.543943368160374,74.29169689145154,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-05,18.5,18.5,15.100000381469727,18.0,37413,0.0,0.0,18.91500015258789,16.31875,13.18374995390574,-4.837431378305871,15.909614110075148,23.77927415989488,54.93771083696124,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-06,18.0,19.850000381469727,17.0,17.649999618530273,14075,0.0,0.0,18.940000152587892,16.388749980926512,13.212916620572408,-6.81098481343654,15.567082142509742,24.03582381962024,52.01889674002083,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-07,17.649999618530273,17.700000762939453,16.649999618530273,17.299999237060547,13547,0.0,0.0,18.85,16.43624997138977,13.24041661421458,-8.222815718511695,14.685527616164235,24.136954676669497,49.20364131984925,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-08,18.350000381469727,18.350000381469727,17.200000762939453,17.450000762939453,5144,0.0,0.0,18.725,16.496249985694885,13.26833328406016,-6.809074697252594,13.510646457454452,24.327974226518446,50.44154336869681,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-09,18.350000381469727,18.350000381469727,16.850000381469727,17.350000381469727,9021,0.0,0.0,18.535000038146972,16.53875000476837,13.294999957084656,-6.393308088688383,12.070138509881655,24.39827046374063,49.57418230354775,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-12,17.350000381469727,17.799999237060547,16.75,17.0,8158,0.0,0.0,18.314999961853026,16.58250000476837,13.319999957084656,-7.179906986578996,10.44776093222655,24.4932436801432,46.556696353006004,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-13,17.0,17.0,15.5,15.600000381469727,22365,0.0,0.0,17.939999961853026,16.591250014305114,13.33583329518636,-13.043475949604186,8.129284691539265,24.41104839165779,36.88533672652523,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-14,16.600000381469727,16.600000381469727,15.0,16.200000762939453,14530,0.0,0.0,17.570000076293944,16.63250002861023,13.355833299954732,-7.797377959052724,5.636555214616453,24.53360007620494,42.407156076625995,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-15,16.549999237060547,16.549999237060547,15.100000381469727,15.649999618530273,16924,0.0,0.0,17.195000076293944,16.683750009536745,13.369999965031942,-8.985172729912927,3.064359430373622,24.784966740251484,39.035749017466244,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-16,15.649999618530273,18.549999237060547,15.300000190734863,16.200000762939453,11961,0.0,0.0,16.84000015258789,16.7400000333786,13.392083303133647,-3.8004714005307507,0.5973722760447818,24.9992227084009,43.84365085467788,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-19,15.850000381469727,16.850000381469727,15.850000381469727,16.649999618530273,8771,0.0,0.0,16.705000114440917,16.80125002861023,13.419999965031941,-0.3292457080745406,-0.5728735302755004,25.19560411616023,47.49232938738259,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-20,18.5,18.5,16.450000762939453,16.950000762939453,4341,0.0,0.0,16.635000228881836,16.86500005722046,13.449583307902019,1.8936010202795819,-1.3637701011459724,25.394219814317847,49.832540463292816,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-21,17.700000762939453,17.799999237060547,16.450000762939453,17.799999237060547,10597,0.0,0.0,16.685000228881837,16.95125002861023,13.477083301544189,6.6826430499451845,-1.5706794441649858,25.778327916604727,55.83817875400328,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-22,18.0,18.0,16.649999618530273,17.299999237060547,9428,0.0,0.0,16.670000076293945,17.045000004768372,13.508749961853027,3.7792390994797294,-2.2000582479877973,26.177477952447564,51.9021441835754,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-23,18.0,18.0,16.850000381469727,17.149999618530273,9513,0.0,0.0,16.65,17.133749985694884,13.546666622161865,3.003000711893543,-2.8233748367915505,26.47945405008106,50.74646240570291,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-26,17.149999618530273,17.899999618530273,17.0,17.350000381469727,8304,0.0,0.0,16.685000038146974,17.201250004768372,13.58124996026357,3.985617871155888,-3.001235180456584,26.65439525151446,52.27244075674589,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-27,17.299999237060547,18.850000381469727,16.549999237060547,16.950000762939453,57785,0.0,0.0,16.820000076293944,17.2587500333786,13.618749968210857,0.7728934961702634,-2.5421884912644863,26.727857355956314,49.002486556145485,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-28,17.5,17.5,16.299999237060547,16.299999237060547,13916,0.0,0.0,16.829999923706055,17.292500019073486,13.654583295186361,-3.1491425374219424,-2.67457044879166,26.64245876452046,44.1673402477403,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-29,16.299999237060547,16.299999237060547,14.5,14.649999618530273,64200,0.0,0.0,16.729999923706053,17.271250009536743,13.678749958674112,-12.432757409810048,-3.133821150940583,26.263365159215567,34.7845494130203,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-08-30,15.649999618530273,16.5,14.699999809265137,15.550000190734863,26765,0.0,0.0,16.664999866485594,17.273750019073486,13.711666623751322,-6.690667174819895,-3.5241343189273673,25.97848600805339,42.019808074345626,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-02,16.0,16.0,14.5,15.199999809265137,26151,0.0,0.0,16.51999988555908,17.268750023841857,13.739583285649617,-7.990315287155776,-4.335867606219472,25.686126462643866,40.15409924781035,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-03,15.199999809265137,15.199999809265137,13.949999809265137,14.949999809265137,15601,0.0,0.0,16.319999790191652,17.253750014305115,13.771249953905741,-8.394607834185681,-5.411868279877068,25.288191500813497,38.827955803638254,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-04,14.149999618530273,14.850000381469727,14.149999618530273,14.699999809265137,9080,0.0,0.0,16.00999984741211,17.213750028610228,13.804583287239074,-8.182386324998781,-6.992957253343497,24.695904761736486,37.49439848058124,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-05,14.699999809265137,14.699999809265137,14.100000381469727,14.550000190734863,8205,0.0,0.0,15.734999942779542,17.145000052452087,13.836666623751322,-7.530980339078106,-8.22397261801633,23.909901992014802,36.680377152801285,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-06,14.899999618530273,15.399999618530273,14.5,15.25,15551,0.0,0.0,15.544999980926514,17.092500042915344,13.8799999554952,-1.8977161871243142,-9.053678853903245,23.14481338415488,42.90948440805239,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-09,15.25,15.25,13.850000381469727,14.5,23138,0.0,0.0,15.25999994277954,17.02500002384186,13.91416662534078,-4.980340403861821,-10.367107656919867,22.357310231110514,38.535325592068624,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-10,15.050000190734863,15.050000190734863,13.600000381469727,13.899999618530273,11820,0.0,0.0,14.954999828338623,16.9462500333786,13.946999955177308,-7.054498307711126,-11.75038844061584,21.504625280277082,35.424208525446105,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-11,14.0,14.5,13.449999809265137,14.149999618530273,8858,0.0,0.0,14.739999866485595,16.86875002384186,13.982416621843974,-4.002715422656198,-12.61948961450933,20.64259333746873,37.68180015220139,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-12,14.149999618530273,14.25,12.899999618530273,13.050000190734863,33967,0.0,0.0,14.579999923706055,16.762500047683716,14.004916620254516,-10.493825383932407,-13.020134930763176,19.690109567957467,32.32663063668036,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-13,14.199999809265137,14.199999809265137,13.050000190734863,14.050000190734863,20947,0.0,0.0,14.429999923706054,16.6962500333786,14.030749956766764,-2.63340079681439,-13.573407831949883,18.99755953762341,40.592275184859005,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-16,14.5,14.5,13.0,13.600000381469727,2347,0.0,0.0,14.269999980926514,16.6025000333786,14.056166625022888,-4.695161880534815,-14.04908928030536,18.11541849413418,38.32384699378142,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-17,13.949999809265137,14.300000190734863,13.100000381469727,13.899999618530273,18174,0.0,0.0,14.164999961853027,16.515000033378602,14.087416625022888,-1.8708107591698664,-14.229488748265032,17.232282347948022,40.702918335941725,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-18,13.899999618530273,13.899999618530273,13.300000190734863,13.350000381469727,5012,0.0,0.0,14.030000019073487,16.393750023841857,14.11366662979126,-4.846754359795548,-14.418604659279952,16.1551456036079,37.8224292886248,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-19,14.350000381469727,14.350000381469727,13.0,13.600000381469727,5664,0.0,0.0,13.935000038146972,16.266250014305115,14.139916634559631,-2.4040161877300776,-14.331821864953257,15.037807044409817,39.90426723194737,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-20,13.050000190734863,13.949999809265137,12.800000190734863,13.649999618530273,30400,0.0,0.0,13.775,16.126250004768373,14.151166629791259,-0.9074437856241518,-14.580265120986786,13.957035675201062,40.33454034873437,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-23,13.649999618530273,13.649999618530273,13.149999618530273,13.600000381469727,13554,0.0,0.0,13.685000038146972,15.986249995231628,14.177833302815754,-0.6211155019386846,-14.395183096542787,12.755240196375542,40.02591857119478,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-24,13.100000381469727,14.649999618530273,12.850000381469727,14.449999809265137,24880,0.0,0.0,13.74000005722046,15.863749980926514,14.212416632970173,5.167392642560926,-13.387439453215698,11.618948350596146,47.39504561454452,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-25,14.800000190734863,14.800000190734863,13.5,13.899999618530273,8870,0.0,0.0,13.71500005722046,15.713749980926513,14.234916631380717,1.3488848745021944,-12.71975133963665,10.388774222152625,43.65707435877174,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-26,13.899999618530273,14.899999618530273,13.899999618530273,14.600000381469727,13532,0.0,0.0,13.870000076293945,15.59375,14.249083304405213,5.2631600660440485,-11.0541077271731,9.436864581871546,49.15354654550037,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-27,15.699999809265137,15.699999809265137,14.5,14.75,10398,0.0,0.0,13.940000057220459,15.46875,14.268249972661335,5.810616495370729,-9.882827912918245,8.413786060931658,50.27301810889891,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-09-30,14.75,15.649999618530273,14.550000190734863,14.899999618530273,1339,0.0,0.0,14.069999980926514,15.391249990463256,14.29158329963684,5.899073480660398,-8.584423034876416,7.69450569451153,51.424751904797226,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-01,15.449999809265137,15.449999809265137,14.600000381469727,15.149999618530273,7708,0.0,0.0,14.194999980926514,15.328749990463256,14.316166631380717,6.727718484585907,-7.396232636334352,7.073006239414529,53.36349619726187,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-02,15.949999809265137,15.949999809265137,14.75,15.149999618530273,3116,0.0,0.0,14.374999904632569,15.275,14.342833296457927,5.391302393316531,-5.891980984402171,6.499181049341756,53.36349619726187,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-03,15.0,15.550000190734863,14.100000381469727,14.600000381469727,2582,0.0,0.0,14.474999904632568,15.203749990463256,14.365749963124593,0.863561158277819,-4.79322592312953,5.833319036525932,48.43147797463666,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-04,14.600000381469727,14.649999618530273,13.75,14.600000381469727,9876,0.0,0.0,14.569999980926514,15.134999990463257,14.392416636149088,0.2059052888296877,-3.7330691106227665,5.159545982354625,48.43147797463665,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-07,14.550000190734863,15.0,14.0,14.449999809265137,9259,0.0,0.0,14.654999923706054,15.071249985694886,14.419916637738545,-1.398840774535299,-2.761881478868189,4.516900924737163,47.055870876663725,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-08,14.449999809265137,14.449999809265137,13.0,13.600000381469727,10120,0.0,0.0,14.569999980926514,15.021249985694885,14.44199997584025,-6.657512702310278,-3.004077591399566,4.010871145434503,40.10450364743365,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-09,13.600000381469727,14.100000381469727,13.100000381469727,13.449999809265137,11492,0.0,0.0,14.525,14.952499961853027,14.470749974250793,-7.401034015386325,-2.8590534221278645,3.3291293710378382,39.00932782026455,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-10,13.5,13.5,12.850000381469727,13.149999618530273,5321,0.0,0.0,14.379999923706055,14.889999961853027,14.496583302815756,-8.553548760094728,-3.4251177935094046,2.7138578161438605,36.84236479696008,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-11,13.149999618530273,13.949999809265137,12.75,12.800000190734863,5053,0.0,0.0,14.184999942779541,14.804999947547913,14.523083305358886,-9.763833328386239,-4.187774447584915,1.9411624670981649,34.43877053107259,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-14,12.5,13.149999618530273,12.100000381469727,13.100000381469727,20619,0.0,0.0,14.005000019073487,14.7162499666214,14.552749975522358,-6.461975268627176,-4.833092324207127,1.1234989357616048,38.16271304197515,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-15,13.149999618530273,15.0,12.649999618530273,15.0,8515,0.0,0.0,13.99000005722046,14.667499947547913,14.59708330631256,7.219442020361274,-4.619055004262788,0.4824021330679171,55.42974416526683,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-16,14.899999618530273,14.899999618530273,13.25,14.25,18012,0.0,0.0,13.900000095367432,14.578749966621398,14.630833307902018,2.517984908138351,-4.655748077221917,-0.3559834233945482,49.54824603711388,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-17,14.5,14.949999809265137,13.600000381469727,13.649999618530273,4398,0.0,0.0,13.805000019073486,14.487499976158142,14.65833330154419,-1.1227845007537707,-4.71095743370379,-1.1654348545073026,45.398149613341154,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-18,13.649999618530273,13.699999809265137,13.0,13.5,8312,0.0,0.0,13.694999980926514,14.396249985694885,14.687083299954732,-1.4238771902015144,-4.871060209882304,-1.9801978944365626,44.39698229336824,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-21,13.75,13.899999618530273,12.5,12.949999809265137,10339,0.0,0.0,13.544999980926514,14.28624997138977,14.7099999666214,-4.392766131408128,-5.1885553728075156,-2.880693379967129,40.84052801055172,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-22,12.649999618530273,13.25,11.800000190734863,13.0,13303,0.0,0.0,13.484999942779542,14.187499952316283,14.733749969800312,-3.596588393307572,-4.951541934081558,-3.7074744623987423,41.30087878954131,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-23,13.199999809265137,14.449999809265137,12.649999618530273,14.449999809265137,12231,0.0,0.0,13.584999942779541,14.141249966621398,14.766666634877522,6.367315937644482,-3.93352797775878,-4.235327333651229,52.777085197749955,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-24,12.699999809265137,14.850000381469727,12.699999809265137,14.0,2987,0.0,0.0,13.669999980926514,14.124999976158142,14.79416663646698,2.4140454976878463,-3.2212389097319,-4.523179147241526,49.540016150240234,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-25,14.0,14.399999618530273,13.050000190734863,13.699999809265137,8472,0.0,0.0,13.75999994277954,14.078749966621398,14.822083298365275,-0.4360474837493602,-2.264050605327649,-5.015039497354996,47.45052070349144,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-28,13.699999809265137,15.949999809265137,13.149999618530273,14.100000381469727,23934,0.0,0.0,13.859999942779542,14.051249980926514,14.851249965031942,1.7316049039034422,-1.3610891444289945,-5.386751862564232,50.451347299619115,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-29,14.100000381469727,14.199999809265137,13.550000190734863,14.149999618530273,9073,0.0,0.0,13.774999904632569,14.031249976158142,14.880416631698608,2.7223209908813937,-1.826281136470322,-5.706605376435174,50.82932493371493,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-30,14.149999618530273,15.050000190734863,13.600000381469727,14.899999618530273,28865,0.0,0.0,13.839999866485595,14.03624997138977,14.913749965031942,7.658957819873486,-1.3981662146527294,-5.883832005361719,56.22386293935312,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-10-31,15.0,15.699999809265137,14.25,14.899999618530273,8560,0.0,0.0,13.964999866485595,14.044999957084656,14.952083293596903,6.69530799129165,-0.5695983684122882,-6.066601681524192,56.223862939353104,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-01,14.899999618530273,15.5,14.25,15.399999618530273,2392,0.0,0.0,14.154999828338623,14.048749947547913,14.998749955495198,8.795477253903837,0.7562941983265545,-6.33386122687662,59.646838218139784,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-04,14.899999618530273,15.699999809265137,13.850000381469727,14.699999809265137,13285,0.0,0.0,14.329999828338623,14.053749942779541,15.037499952316285,2.5819957108081137,1.965666720155443,-6.541978471529189,53.35660022675028,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-05,14.0,14.449999809265137,13.300000190734863,13.949999809265137,7747,0.0,0.0,14.424999809265136,14.054999947547913,15.068333284060161,-3.2928943243029267,2.6325141451300773,-6.724919852842583,47.56836824017348,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-06,14.300000190734863,14.300000190734863,13.199999809265137,13.449999809265137,18192,0.0,0.0,14.324999809265137,14.037499952316285,15.095416617393493,-6.108202524610623,2.0480844732000327,-7.008197864895213,44.13122826596245,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-07,13.649999618530273,14.699999809265137,13.350000381469727,14.25,4625,0.0,0.0,14.349999809265137,14.067499947547912,15.127499953905742,-0.6968627915978911,2.008173895649933,-7.007106326806835,50.316970317782065,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-08,14.699999809265137,14.699999809265137,13.600000381469727,13.649999618530273,6246,0.0,0.0,14.34499979019165,14.057499933242799,15.157916617393493,-4.844894958705968,2.0451706086725983,-7.259682922968332,46.18663663411742,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-11,13.649999618530273,13.949999809265137,13.0,13.949999809265137,15400,0.0,0.0,14.329999732971192,14.066249918937682,15.189583285649617,-2.651779000607601,1.8750542294746086,-7.395419252700666,48.464520931762515,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-12,13.699999809265137,14.25,13.300000190734863,13.399999618530273,8313,0.0,0.0,14.254999732971191,14.053749918937683,15.206249952316284,-5.997896390438646,1.4320008196696326,-7.579120670728204,44.726573852043586,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-13,13.350000381469727,13.399999618530273,12.5,12.949999809265137,3545,0.0,0.0,14.059999752044678,14.043749904632568,15.217916615804036,-7.8947365743596105,0.1157087496036237,-7.715686324316419,41.88044422009126,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-14,12.899999618530273,13.199999809265137,12.699999809265137,12.75,4419,0.0,0.0,13.84499979019165,14.022499895095825,15.218749952316283,-7.908991020479407,-1.2658235423931268,-7.860370010471131,40.64258210302081,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-15,12.75,12.75,11.899999618530273,12.100000381469727,11588,0.0,0.0,13.514999866485596,13.983749914169312,15.209999958674112,-10.469844609653125,-3.352105483585245,-8.062130492022005,36.83229280623858,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-18,11.899999618530273,12.600000381469727,11.350000381469727,11.75,14102,0.0,0.0,13.219999885559082,13.937499904632569,15.195833293596904,-11.119515115615409,-5.147982234855501,-8.280779109985112,34.93316292225077,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-19,11.449999809265137,11.949999809265137,11.449999809265137,11.899999618530273,2160,0.0,0.0,13.014999866485596,13.873749899864197,15.187083292007447,-8.567040026074181,-6.189747109301773,-8.647699936132051,36.445601839816305,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-20,12.800000190734863,12.800000190734863,11.399999618530273,11.399999618530273,6035,0.0,0.0,12.80999984741211,13.811249899864197,15.172499958674113,-11.007027678979139,-7.249525276216548,-8.971824435772625,33.63873185742486,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-21,11.449999809265137,12.050000190734863,11.350000381469727,11.399999618530273,7285,0.0,0.0,12.524999809265136,13.73124988079071,15.151666625340779,-8.982037587758402,-8.784707015004175,-9.374656793031983,33.63873185742486,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-22,11.550000190734863,11.75,11.0,11.600000381469727,4767,0.0,0.0,12.319999885559081,13.652499890327453,15.12499996026357,-5.844151873193635,-9.760117307984187,-9.735537678047422,35.927897199086516,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-25,12.0,12.0,11.399999618530273,11.850000381469727,4075,0.0,0.0,12.109999942779542,13.57624990940094,15.095416633288066,-2.146982349614602,-10.800110313276464,-10.063761476692832,38.771125925606086,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-26,14.0,14.0,12.300000190734863,12.850000381469727,29608,0.0,0.0,12.055000019073486,13.518749928474426,15.078749966621398,6.5947769484727266,-10.827553709813483,-10.345685428833407,48.59709055955064,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-27,13.899999618530273,13.949999809265137,12.350000381469727,12.350000381469727,14494,0.0,0.0,11.995000076293945,13.448749947547913,15.053333306312561,2.9595690114031683,-10.809553876187788,-10.65932259728662,44.73173577667524,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-28,11.800000190734863,11.800000190734863,11.300000190734863,11.800000190734863,18053,0.0,0.0,11.900000095367432,13.37874994277954,15.026249972979228,-0.8403353263122869,-11.052974707926166,-10.96414629839304,40.87991074986473,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-11-29,11.5,11.699999809265137,11.199999809265137,11.449999809265137,7387,0.0,0.0,11.835000038146973,13.299999928474426,14.991249974568685,-3.253064872335363,-11.015036828616703,-11.281581248817234,38.60192935727334,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-02,11.199999809265137,11.199999809265137,10.600000381469727,10.699999809265137,19351,0.0,0.0,11.730000019073486,13.206249928474426,14.953333306312562,-8.780905440183503,-11.178418683550346,-11.683571428857292,34.203584439734286,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-03,10.699999809265137,11.5,10.5,10.550000190734863,7811,0.0,0.0,11.595000076293946,13.129999923706055,14.91416664123535,-9.012504343967983,-11.690783368861151,-11.962899171290953,33.38429739564697,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-04,10.5,11.199999809265137,10.399999618530273,10.5,10962,0.0,0.0,11.505000114440918,13.056249928474426,14.880416639645894,-8.735333371961081,-11.88128155122384,-12.25884163963085,33.099684541568436,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-05,10.5,12.0,10.300000190734863,11.5,10805,0.0,0.0,11.515000152587891,13.014999938011169,14.86291663646698,-0.13026619530283018,-11.525161679351443,-12.433069118626737,43.47832194230267,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-06,11.0,13.5,11.0,13.449999809265137,8257,0.0,0.0,11.700000095367432,13.031249928474427,14.858749969800312,14.957262390028609,-10.215826113488138,-12.299150635418124,57.36739581729872,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-09,13.25,13.25,11.350000381469727,12.050000190734863,43581,0.0,0.0,11.720000076293946,13.004999923706055,14.840833306312561,2.8157006168319807,-9.880813955790636,-12.37015027872884,48.20820275149993,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-10,11.5,12.600000381469727,11.399999618530273,11.800000190734863,20082,0.0,0.0,11.61500005722046,12.924999928474426,14.819166644414265,1.5927691141025724,-10.135395578362601,-12.781870677281306,46.77213141504429,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-11,11.5,12.5,11.300000190734863,12.199999809265137,16589,0.0,0.0,11.6,12.873749923706054,14.801249972979228,5.172412148837389,-9.89416394799264,-13.022549127891006,49.370854033927316,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-12,10.199999809265137,12.5,10.199999809265137,12.350000381469727,14480,0.0,0.0,11.655000019073487,12.841249942779541,14.791249974568684,5.963109062710139,-9.237807292841193,-13.183470194485746,50.34980255004178,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-13,12.5,12.5,11.550000190734863,11.75,8493,0.0,0.0,11.685000038146972,12.797499942779542,14.775833304723104,0.556268392304905,-8.693103415564,-13.38897997252843,46.47852028388726,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-16,11.75,12.300000190734863,10.75,11.600000381469727,31419,0.0,0.0,11.775000095367432,12.763749957084656,14.750416644414265,-1.4861971335911426,-7.746546783207767,-13.46854624667112,45.535905270348515,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-17,11.350000381469727,11.699999809265137,10.350000381469727,11.600000381469727,20335,0.0,0.0,11.880000114440918,12.728749966621399,14.724999984105429,-2.3569000864809198,-6.667974894676676,-13.556876194491254,45.535905270348515,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-18,11.649999618530273,12.300000190734863,11.0,11.5,7685,0.0,0.0,11.980000114440918,12.65499997138977,14.696249985694886,-4.00667871331918,-5.333859016000649,-13.889597797343118,44.83289812020556,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-19,11.949999809265137,11.949999809265137,10.5,10.600000381469727,13844,0.0,0.0,11.890000152587891,12.569999980926514,14.655416655540467,-10.849451257890799,-5.409704290934306,-14.229664864734929,38.99753044775424,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-20,10.949999809265137,11.699999809265137,10.0,10.699999809265137,30567,0.0,0.0,11.615000152587891,12.494999980926513,14.615833322207132,-7.877747148534361,-7.042815763760968,-14.510519479298173,39.93303726542572,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-23,10.100000381469727,11.199999809265137,10.0,11.0,10500,0.0,0.0,11.510000133514405,12.41749997138977,14.57916665871938,-4.430930734999773,-7.308233057912361,-14.82709360508462,42.76862083340468,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-27,10.100000381469727,11.449999809265137,10.100000381469727,11.100000381469727,7808,0.0,0.0,11.44000015258789,12.341249990463258,14.542083326975504,-2.9720259316714337,-7.3027435516808366,-15.134236869828065,43.722312162021694,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2024-12-30,11.100000381469727,11.300000190734863,10.100000381469727,11.0,7687,0.0,0.0,11.320000171661377,12.24375,14.497916666666667,-2.8268565972504947,-7.544664243704938,-15.548210949849114,42.951520778803165,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-02,11.199999809265137,11.800000190734863,11.0,11.350000381469727,2191,0.0,0.0,11.220000171661377,12.155000019073487,14.448333342870077,1.1586471285151483,-7.692306424886208,-15.872649594759647,46.50611027182013,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-03,12.0,13.050000190734863,11.25,12.399999618530273,11962,0.0,0.0,11.285000133514405,12.080000019073486,14.407083336512247,9.880367495118781,-6.581124870064826,-16.15235549822339,55.470115463752734,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-07,11.949999809265137,12.350000381469727,11.600000381469727,12.0,8950,0.0,0.0,11.325000095367432,12.012500023841858,14.363749996821086,5.9602640083745415,-5.7232043880117125,-16.369332336608448,51.90201236128831,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-08,11.550000190734863,11.649999618530273,11.149999618530273,11.649999618530273,21127,0.0,0.0,11.330000019073486,11.955000019073486,14.31875,2.8243565659142473,-5.227938092872019,-16.508074943179494,48.93582317473117,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-09,11.699999809265137,11.699999809265137,10.800000190734863,11.149999618530273,14904,0.0,0.0,11.294999980926514,11.897500014305114,14.267916663487751,-1.2837570840291972,-5.064089368810057,-16.613614342510434,44.98097609056126,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-10,10.800000190734863,11.149999618530273,10.199999809265137,10.75,25215,0.0,0.0,11.309999942779541,11.810000014305114,14.213333336512248,-4.951369987734196,-4.233700854529529,-16.909005546455987,42.052958959747336,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-13,10.550000190734863,10.699999809265137,10.300000190734863,10.449999809265137,7193,0.0,0.0,11.28499994277954,11.730000019073486,14.161249995231628,-7.399203701801173,-3.79369203384788,-17.16832890441728,39.95240288574918,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-14,10.699999809265137,10.949999809265137,10.0,10.600000381469727,25092,0.0,0.0,11.244999980926513,11.646250033378601,14.104999995231628,-5.735879062257171,-3.4453154560660297,-17.431761522043516,41.525164133810634,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-15,11.399999618530273,11.399999618530273,10.25,10.899999618530273,7939,0.0,0.0,11.224999904632568,11.583750033378601,14.050833328564961,-2.895325513260512,-3.097012001401047,-17.558270299675723,44.6477498229894,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-16,10.550000190734863,10.75,9.600000381469727,10.25,29188,0.0,0.0,11.149999904632569,11.516250038146973,13.984583322207133,-8.071748092649218,-3.18028987127945,-17.65038848272665,39.70095454830348,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-17,10.199999809265137,10.699999809265137,9.5,10.699999809265137,34549,0.0,0.0,11.08499984741211,11.465000033378601,13.91791664759318,-3.473162322477208,-3.314436850066972,-17.62416514140255,44.301915351644084,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-20,10.5,10.5,9.899999618530273,10.0,17380,0.0,0.0,10.844999885559082,11.412500023841858,13.840833314259847,-7.791608063401287,-4.9726189449919955,-17.544704392300865,39.280917917838906,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-21,10.050000190734863,10.199999809265137,9.779999732971191,9.960000038146973,5946,0.0,0.0,10.640999889373779,11.367750024795532,13.76383330821991,-6.399773125708425,-6.393086880310994,-17.408546222318833,39.00885021795034,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-22,10.699999809265137,10.699999809265137,9.260000228881836,9.800000190734863,21192,0.0,0.0,10.455999946594238,11.315250039100647,13.684249973297119,-6.273907414020684,-7.593734911179245,-17.311872691738607,37.87870271808719,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-23,9.640000343322754,10.050000190734863,9.640000343322754,9.800000190734863,12778,0.0,0.0,10.321000003814698,11.275250053405761,13.600083311398825,-5.047958656014631,-8.46322737918195,-17.0942574744709,37.87870271808719,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-24,9.65999984741211,10.100000381469727,9.65999984741211,9.84000015258789,12975,0.0,0.0,10.230000019073486,11.236250066757203,13.520416649182637,-3.812315403308448,-8.955390292182429,-16.894202609972982,38.396177293202065,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-27,9.979999542236328,9.979999542236328,9.5,9.640000343322754,30213,0.0,0.0,10.149000072479248,11.187250065803529,13.43616665204366,-5.01526973614607,-9.280654202036088,-16.73778425409801,36.74788024747997,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-28,9.859999656677246,9.960000038146973,9.699999809265137,9.800000190734863,20368,0.0,0.0,10.069000053405762,11.136000061035157,13.367833320299784,-2.6715648152163034,-9.581537372317598,-16.69554972588914,39.00380648752176,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-29,9.65999984741211,10.5,9.5,9.979999542236328,36526,0.0,0.0,9.977000045776368,11.064250040054322,13.303916652997335,0.03006411191939429,-9.826693995001365,-16.834641041128464,41.53029188502775,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-30,10.0,10.0,9.579999923706055,9.779999732971191,13559,0.0,0.0,9.930000019073486,11.000000023841858,13.241249990463256,-1.510576896416662,-9.727272749538274,-16.92627182656934,39.56912810372986,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-01-31,9.859999656677246,9.859999656677246,9.539999961853027,9.680000305175781,5475,0.0,0.0,9.82800006866455,10.94700002670288,13.17649998664856,-1.505899088876177,-10.221978216029665,-16.92027444469153,38.58793819766837,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-03,9.539999961853027,9.680000305175781,9.319999694824219,9.5,6655,0.0,0.0,9.77800006866455,10.898250031471253,13.11108331680298,-2.8431178841515234,-10.279172890800988,-16.87757778562653,36.81815906332659,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-04,9.319999694824219,9.619999885559082,8.979999542236328,9.0,25610,0.0,0.0,9.682000064849854,10.855750036239623,13.044416650136311,-7.043999796341978,-10.812242060396136,-16.778570269555264,32.37619761786857,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-05,9.0,9.579999923706055,8.699999809265137,9.0,26144,0.0,0.0,9.602000045776368,10.817000031471252,12.989416646957398,-6.2695276286857515,-11.232319332161717,-16.724512536096114,32.376197617868584,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-06,8.899999618530273,9.140000343322754,8.0,8.5,75507,0.0,0.0,9.472000026702881,10.767000031471252,12.925249973932901,-10.261824577308683,-12.02749141806602,-16.697935798644643,28.402148138209085,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-07,8.479999542236328,8.5,6.820000171661377,7.579999923706055,265856,0.0,0.0,9.246000003814697,10.669000029563904,12.857999976476034,-18.018603497958974,-13.337707580898492,-17.024420212450995,22.8455232505911,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-10,7.519999980926514,8.199999809265137,7.320000171661377,7.800000190734863,110622,0.0,0.0,9.061999988555907,10.527750039100647,12.787999971707661,-13.926283374694117,-13.922728456705972,-17.67477273700047,26.54630575537196,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-11,7.800000190734863,8.039999961853027,7.579999923706055,7.739999771118164,16728,0.0,0.0,8.855999946594238,10.420000028610229,12.713749972979228,-12.60162807369094,-15.00959767487246,-18.04149011301897,26.177517858485245,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-12,7.5,8.380000114440918,7.5,7.800000190734863,22796,0.0,0.0,8.638000011444092,10.32000002861023,12.637499968210856,-9.701317661484149,-16.2984497335573,-18.3382784999423,27.265687459206717,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-13,7.900000095367432,7.980000019073486,7.539999961853027,7.800000190734863,17588,0.0,0.0,8.440000057220459,10.210000038146973,12.554166642824809,-7.582936755291522,-17.33594490022895,-18.672419057123303,27.265687459206717,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-14,8.4399995803833,8.899999618530273,7.639999866485596,8.859999656677246,32435,0.0,0.0,8.357999992370605,10.12275002002716,12.483833312988281,6.006217573161994,-17.4335039802931,-18.91312735251464,44.13712099818947,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-17,8.880000114440918,8.880000114440918,8.0,8.0,18688,0.0,0.0,8.207999992370606,10.02900002002716,12.407583316167196,-2.5341129698336213,-18.15734394276751,-19.170399549449087,36.69927123110039,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-18,7.599999904632568,7.960000038146973,7.139999866485596,7.340000152587891,28984,0.0,0.0,8.042000007629394,9.922500014305115,12.32416664759318,-8.729170036999758,-18.951877087071132,-19.487456652958308,32.21282511444636,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-19,7.900000095367432,8.15999984741211,7.400000095367432,7.440000057220459,13863,0.0,0.0,7.88600001335144,9.818500006198883,12.244916641712189,-5.655591622823715,-19.682232434968324,-19.815705623080692,33.53855554736586,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-20,7.440000057220459,7.78000020980835,7.380000114440918,7.480000019073486,14471,0.0,0.0,7.784000015258789,9.71800000667572,12.171416648228963,-3.9054470142520357,-19.901214139621132,-20.157198726002324,34.09379291260133,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-21,7.860000133514404,7.860000133514404,7.059999942779541,7.28000020980835,10333,0.0,0.0,7.754000043869018,9.635000002384185,12.109999986489614,-6.112971774296723,-19.522573513748963,-20.437654722267833,32.626120818898855,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-24,7.0,7.559999942779541,6.800000190734863,6.840000152587891,31966,0.0,0.0,7.658000040054321,9.538500010967255,12.03741665283839,-10.681638589553051,-19.714839531904985,-20.759575862001068,29.606523906774385,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-25,7.440000057220459,7.599999904632568,6.960000038146973,7.440000057220459,17326,0.0,0.0,7.628000068664551,9.449500012397767,11.972749988238016,-2.4646042180359493,-19.276151556626317,-21.0749408307956,38.02926261368107,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-26,7.440000057220459,7.5,6.800000190734863,7.5,49769,0.0,0.0,7.5980000495910645,9.359500002861022,11.91066665649414,-1.2898137529801539,-18.820449305320803,-21.419175997525937,38.81763519913243,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-27,7.579999923706055,7.679999828338623,6.900000095367432,7.0,13355,0.0,0.0,7.5180000305175785,9.259500002861023,11.84649999141693,-6.890130731775438,-18.807710695019722,-21.837673493692233,34.83998439994862,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-02-28,7.400000095367432,7.400000095367432,6.900000095367432,7.119999885559082,6952,0.0,0.0,7.344000053405762,9.153749990463258,11.784583322207133,-3.0501111957753917,-19.770585158464733,-22.324364466805328,36.52119391750961,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-03,7.739999771118164,7.739999771118164,7.039999961853027,7.380000114440918,12342,0.0,0.0,7.2820000648498535,9.028250002861023,11.718999989827473,1.3457847942642815,-19.342064491543642,-22.96057674974077,40.125801210399494,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-04,6.920000076293945,7.380000114440918,6.900000095367432,7.099999904632568,20722,0.0,0.0,7.258000040054322,8.905750000476838,11.657333322366078,-2.1769100929981637,-18.502090900084674,-23.603883030521036,37.6465330436738,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-05,7.28000020980835,7.28000020980835,6.880000114440918,6.980000019073486,19088,0.0,0.0,7.212000036239624,8.789000010490417,11.599666659037272,-3.2168610094337176,-17.942882835004088,-24.230581198271516,36.602725642332736,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-06,4.679999828338623,4.679999828338623,3.5,3.7100000381469727,579906,0.0,0.0,6.835000038146973,8.603000020980835,11.512666662534079,-45.720555706788474,-20.550970341998102,-25.273611465032992,20.18160715904,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-07,3.75,3.7799999713897705,3.559999942779541,3.569999933242798,125461,0.0,0.0,6.464000010490418,8.423500019311906,11.43366666038831,-44.77104072634515,-23.262301944905253,-26.32722057137682,19.772611558002538,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-10,3.5,3.7799999713897705,3.3499999046325684,3.5899999141693115,258188,0.0,0.0,6.138999986648559,8.25200002193451,11.34649999141693,-41.52142169771878,-25.605914077428732,-27.272727024397458,20.02196737802342,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-11,3.5899999141693115,3.7699999809265137,3.5899999141693115,3.6500000953674316,35883,0.0,0.0,5.759999990463257,8.078250014781952,11.26358332236608,-36.63194268384235,-28.69742852816706,-28.279928477636563,20.817093382738904,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-12,3.759999990463257,3.8399999141693115,3.740000009536743,3.75,74624,0.0,0.0,5.384999990463257,7.899500024318695,11.17899999221166,-30.36211686831595,-31.831128883024533,-29.336255212253082,22.205277539868305,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-13,3.799999952316284,4.0,3.509999990463257,3.799999952316284,81623,0.0,0.0,5.064999985694885,7.738250023126602,11.099416655302047,-24.975321558763067,-34.54592484660509,-30.282371916994933,22.932789224496005,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-14,3.799999952316284,3.8399999141693115,3.380000114440918,3.8399999141693115,67569,0.0,0.0,4.736999988555908,7.566750025749206,11.018083318074543,-18.936037081563313,-37.39716559373343,-31.324262058026193,23.548744430013315,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-17,3.7300000190734863,3.880000114440918,3.630000114440918,3.880000114440918,31070,0.0,0.0,4.386999988555909,7.413750028610229,10.936666655540467,-11.556869738718243,-40.82616797671705,-32.21197772490893,24.201167451583544,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-18,3.9000000953674316,3.9000000953674316,3.5999999046325684,3.7899999618530273,32763,0.0,0.0,4.055999994277954,7.259500026702881,10.854916652043661,-6.558186213022416,-44.12838378182212,-33.1224710478442,23.71087191146394,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-19,3.940000057220459,3.940000057220459,3.7200000286102295,3.7899999618530273,37155,0.0,0.0,3.736999988555908,7.109250020980835,10.766083319981893,1.4182492228906847,-47.434680486306355,-33.96623628403434,23.71087191146394,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-20,3.940000057220459,4.239999771118164,3.8499999046325684,3.9200000762939453,29008,0.0,0.0,3.7579999923706056,6.962250018119812,10.682916657129924,4.31080586088952,-46.023196774173435,-34.8281911993284,26.2150168623959,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-21,3.859999895095825,3.930000066757202,3.799999952316284,3.859999895095825,14242,0.0,0.0,3.786999988555908,6.81275001168251,10.593416653076808,1.9276447520601692,-44.41304932572079,-35.688831707532444,25.794181644111262,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-24,3.9100000858306885,3.990000009536743,3.8499999046325684,3.990000009536743,10184,0.0,0.0,3.8269999980926515,6.67150000333786,10.503749986489614,4.2592111712916045,-42.636588530646165,-36.484588723845896,28.473383727334564,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-25,3.990000009536743,4.190000057220459,3.9100000858306885,4.130000114440918,6103,0.0,0.0,3.875,6.529750001430512,10.413999990622203,6.580648114604334,-40.65622728050721,-37.29834830698536,31.348064402945113,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-26,4.099999904632568,4.099999904632568,3.799999952316284,3.9800000190734863,31541,0.0,0.0,3.8980000019073486,6.37975001335144,10.320916660626729,2.103643333145559,-38.900427230695946,-38.18620745490996,29.958771591364098,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-27,3.9800000190734863,3.9800000190734863,3.809999942779541,3.930000066757202,2200,0.0,0.0,3.9110000133514404,6.2335000216960905,10.227416664361954,0.48581061981332146,-37.25836208006805,-39.051079795965535,29.48961810813296,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-28,4.079999923706055,4.079999923706055,3.7100000381469727,3.890000104904175,40551,0.0,0.0,3.9160000324249267,6.088750016689301,10.138166662057241,-0.6639409424277196,-35.68466398372167,-39.94229706760641,29.097050393417803,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-03-31,3.869999885559082,3.890000104904175,3.5899999141693115,3.75,38020,0.0,0.0,3.903000020980835,5.945000016689301,10.04774999221166,-3.9200620076447126,-34.34819158916725,-40.83252448262083,27.70682364852881,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-01,3.9800000190734863,4.190000057220459,3.5199999809265137,3.740000009536743,54338,0.0,0.0,3.8980000257492065,5.813500016927719,9.95849999388059,-4.053361086935736,-32.94916978758011,-41.62273414168737,27.605365697875044,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-02,3.740000009536743,3.8299999237060547,3.5299999713897705,3.8299999237060547,14482,0.0,0.0,3.9020000219345095,5.68425001502037,9.877083323399226,-1.8452100928681954,-31.35418020629541,-42.45011579932567,30.0867058525386,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-03,3.759999990463257,3.880000114440918,3.740000009536743,3.869999885559082,26327,0.0,0.0,3.8970000028610228,5.5685000121593475,9.797249990701676,-0.692843656200111,-30.017060351054077,-43.16262198633014,31.215136748570515,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-04,3.759999990463257,3.859999895095825,3.680000066757202,3.859999895095825,33539,0.0,0.0,3.8970000028610228,5.475500011444092,9.719833326339721,-0.9494510581994755,-28.82841759262019,-43.66672938098573,31.080078224880552,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-07,3.6600000858306885,3.859999895095825,3.609999895095825,3.7699999809265137,56624,0.0,0.0,3.875,5.374750006198883,9.644583324591318,-2.7096779115738405,-27.903623507496533,-44.27182776787681,29.82917091137928,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-08,3.7699999809265137,3.7699999809265137,3.640000104904175,3.740000009536743,10391,0.0,0.0,3.8359999895095824,5.274750012159347,9.566583321491878,-2.5026063669283922,-27.276174592789427,-44.86275993322173,29.404338279976088,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-09,3.740000009536743,3.799999952316284,3.5999999046325684,3.700000047683716,23850,0.0,0.0,3.8079999923706054,5.1722500085830685,9.472416655222576,-2.836133006913586,-26.37633552029705,-45.396721904843886,28.81506106459257,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-10,3.9200000762939453,3.9800000190734863,3.680000066757202,3.7200000286102295,14424,0.0,0.0,3.786999988555908,5.070250004529953,9.384666655460993,-1.7692094044929625,-25.309403181845884,-45.973041018142666,29.57501919186558,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-11,3.9100000858306885,3.9100000858306885,3.7100000381469727,3.75,8242,0.0,0.0,3.772999978065491,4.942500013113022,9.302166658639909,-0.6095939093348064,-23.66211496094512,-46.86721712814726,30.768947970537127,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-14,4.0,4.050000190734863,3.6700000762939453,3.7200000286102295,50145,0.0,0.0,3.7699999809265137,4.835500013828278,9.220666658878326,-1.3262586888394683,-22.034950467474097,-47.558021640742126,30.217262577674475,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-15,3.7200000286102295,3.809999942779541,3.2300000190734863,3.6700000762939453,49368,0.0,0.0,3.762999987602234,4.743750011920929,9.143333327770232,-2.4714300189925797,-20.67457226569894,-48.11793640385877,29.275131930094048,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-16,3.450000047683716,3.680000066757202,3.309999942779541,3.680000066757202,19732,0.0,0.0,3.7480000019073487,4.649750012159347,9.065666661659877,-1.8142992293367546,-19.393515950188153,-48.710335536338796,29.746908245284047,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-17,3.680000066757202,3.680000066757202,3.509999990463257,3.680000066757202,10581,0.0,0.0,3.7290000200271605,4.55475001335144,8.975916663805643,-1.3140239476212559,-18.12942512550064,-49.25587899319577,29.746908245284047,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-22,3.8399999141693115,4.230000019073486,3.680000066757202,3.9600000381469727,12060,0.0,0.0,3.7390000343322756,4.471750009059906,8.892249997456869,5.91067135023881,-16.386201671449786,-49.711827598877676,42.2553570698298,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-23,3.940000057220459,3.940000057220459,3.740000009536743,3.799999952316284,25698,0.0,0.0,3.7420000314712523,4.395750004053116,8.809749998648961,1.5499711479753229,-14.872319216949807,-50.103578367975985,38.082700309614296,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-24,3.7100000381469727,3.990000009536743,3.680000066757202,3.75,13742,0.0,0.0,3.743000030517578,4.303500002622604,8.723499995470046,0.18701494590834739,-13.02428190457652,-50.66773651794196,36.85781744810069,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-25,3.759999990463257,3.890000104904175,3.609999895095825,3.759999990463257,21381,0.0,0.0,3.7490000247955324,4.210000002384186,8.636916665236155,0.29341065870823413,-10.950118226308375,-51.25575288540689,37.29223049026121,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-28,3.759999990463257,4.059999942779541,3.6600000858306885,3.950000047683716,21528,0.0,0.0,3.772000026702881,4.133750003576279,8.545666668812434,4.718982495247362,-8.751133391241195,-51.62753049258902,45.03050047648403,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-29,3.809999942779541,4.0,3.809999942779541,4.0,25894,0.0,0.0,3.797000026702881,4.055750006437302,8.454833338658014,5.346325306017808,-6.379830594186823,-52.030396768518116,46.88794632381861,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-04-30,3.869999885559082,4.0,3.7899999618530273,3.8299999237060547,7134,0.0,0.0,3.808000016212463,3.96700000166893,8.35841667453448,0.5777286607123802,-4.008066180730399,-52.53885806201601,41.72545146640236,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-02,3.990000009536743,4.369999885559082,3.990000009536743,4.039999961853027,45246,0.0,0.0,3.8450000047683717,3.8905000030994414,8.269583342472712,5.0715203340137,-1.1695154426120375,-52.95409887076449,49.170524910985286,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-05,4.039999961853027,4.480000019073486,3.799999952316284,3.799999952316284,54481,0.0,0.0,3.85699999332428,3.8110000014305117,8.185000010331471,-1.4778335780827494,1.207032061834201,-53.43921812315091,42.48943131428062,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-06,3.799999952316284,3.799999952316284,3.4100000858306885,3.5,43637,0.0,0.0,3.8389999866485596,3.805750000476837,8.102083345254263,-8.830424272663413,0.8736776237944314,-53.02751356284149,35.91941335772373,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-07,3.2899999618530273,3.5799999237060547,3.2100000381469727,3.2100000381469727,63365,0.0,0.0,3.7639999866485594,3.7967500030994414,8.010083345572154,-14.718383381155764,-0.8625802706037236,-52.60036831953534,30.93911892944267,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-08,3.2100000381469727,3.2899999618530273,3.009999990463257,3.190000057220459,81999,0.0,0.0,3.702999997138977,3.78675000667572,7.9229166825612385,-13.853630578311463,-2.2116593223502736,-52.20510124749187,30.623763243418907,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-09,3.4000000953674316,3.4000000953674316,3.119999885559082,3.2100000381469727,19642,0.0,0.0,3.6490000009536745,3.7757500052452087,7.833416684468587,-12.030692318223299,-3.3569490595366527,-51.79944898461185,31.377026768415647,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-12,3.109999895095825,3.75,3.109999895095825,3.240000009536743,45265,0.0,0.0,3.597000002861023,3.7630000054836272,7.7487500210603075,-9.924937254387686,-4.411373967066196,-51.43732866260778,32.55987897234442,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-13,3.0799999237060547,3.380000114440918,3.049999952316284,3.319999933242798,25547,0.0,0.0,3.5339999914169313,3.75100000500679,7.668500022093455,-6.055462894563611,-5.785124321519851,-51.08561003847022,35.74077763709097,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-14,3.450000047683716,3.450000047683716,3.0999999046325684,3.25,16318,0.0,0.0,3.458999991416931,3.7362500071525573,7.589333355426788,-6.042208497702749,-7.420542394242023,-50.76972070964659,34.21987085874005,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-15,3.490000009536743,3.490000009536743,3.240000009536743,3.240000009536743,1355,0.0,0.0,3.4,3.720250004529953,7.515500018994014,-4.705882072448728,-8.60829256474703,-50.49896886264759,33.997299303760144,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-16,3.240000009536743,3.440000057220459,3.059999942779541,3.140000104904175,72921,0.0,0.0,3.310000014305115,3.704000008106232,7.443750019868215,-5.135948902303224,-10.637148837441819,-50.24013436480491,31.771846287607374,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-19,3.059999942779541,3.200000047683716,3.059999942779541,3.130000114440918,105463,0.0,0.0,3.243000030517578,3.687500011920929,7.370666690667471,-3.4844253781467134,-12.05423674485082,-49.97060419799016,31.549438327674395,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-20,3.299999952316284,3.299999952316284,3.0999999046325684,3.200000047683716,45350,0.0,0.0,3.21300003528595,3.669500011205673,7.302333360910415,-0.40460589665312613,-12.440386279484786,-49.74893873171274,34.980542760738146,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-21,3.25,3.259999990463257,3.0199999809265137,3.190000057220459,117604,0.0,0.0,3.2110000371932985,3.652750015258789,7.233916697899501,-0.6540012372966334,-12.093627437414261,-49.50522424014875,34.71285170703018,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-22,3.190000057220459,3.190000057220459,3.069999933242798,3.190000057220459,39848,0.0,0.0,3.2110000371932985,3.632750016450882,7.16383336186409,-0.6540012372966334,-11.609661478155445,-49.29041711397918,34.71285170703018,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-23,3.190000057220459,3.5899999141693115,3.109999895095825,3.299999952316284,150127,0.0,0.0,3.2200000286102295,3.612000012397766,7.092583358287811,2.484469658237336,-10.85271269219387,-49.073562763600385,40.51972479762638,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-26,3.5,3.5,3.2300000190734863,3.4000000953674316,37838,0.0,0.0,3.2360000371932984,3.5975000143051146,7.013833355903626,5.067986906340597,-10.04864421610413,-48.70850458291746,45.284254006798655,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-27,3.4000000953674316,3.5,3.3299999237060547,3.5,99241,0.0,0.0,3.2540000438690186,3.586750012636185,6.940083352724711,7.559924794545683,-9.277199905063974,-48.318343882310735,49.62943153302676,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-28,3.690000057220459,3.690000057220459,3.299999952316284,3.4800000190734863,5846,0.0,0.0,3.2770000457763673,3.5765000104904177,6.870750017960867,6.194689364095676,-8.374107754384776,-47.946002967055,48.79482147848897,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-05-30,3.4000000953674316,3.4600000381469727,3.25,3.4600000381469727,31016,0.0,0.0,3.29900004863739,3.5692500114440917,6.804166686534882,4.880266357561334,-7.571617621074421,-47.543172060915765,47.92684523700219,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-02,3.390000104904175,3.390000104904175,3.299999952316284,3.299999952316284,14826,0.0,0.0,3.315000033378601,3.5582500100135803,6.742500021060308,-0.4524911285454532,-6.836224996850369,-47.226548032638796,41.55795721195431,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-03,3.4000000953674316,3.5399999618530273,3.299999952316284,3.5199999809265137,3340,0.0,0.0,3.3540000200271605,3.550500011444092,6.683916685978572,4.949313056295359,-5.534431510591916,-46.87994811646468,51.16709713437483,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-04,3.4600000381469727,3.4600000381469727,3.309999942779541,3.4000000953674316,10678,0.0,0.0,3.3740000247955324,3.5387500166893004,6.624750020106633,0.7706007818857341,-4.655598477337512,-46.58288983057598,46.66047578014341,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-05,3.3399999141693115,3.4000000953674316,3.2799999713897705,3.4000000953674316,32836,0.0,0.0,3.3950000286102293,3.5272500216960907,6.557250020901362,0.14727737010503483,-3.7493796093952114,-46.20839512824869,46.6604757801434,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-09,3.4000000953674316,3.4000000953674316,3.200000047683716,3.299999952316284,37416,0.0,0.0,3.406000018119812,3.515500020980835,6.472666688760122,-3.1121569359838768,-3.114777477101886,-45.686991312474795,43.00015250517692,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-10,3.299999952316284,3.299999952316284,3.0999999046325684,3.2799999713897705,82658,0.0,0.0,3.4040000200271607,3.504000020027161,6.399583353598913,-3.6427746153891274,-2.8538812622274174,-45.24643517524265,42.28569339126295,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-11,3.2799999713897705,3.390000104904175,3.2699999809265137,3.390000104904175,49961,0.0,0.0,3.403000020980835,3.496250021457672,6.3295000195503235,-0.3820133998386855,-2.667143365163538,-44.76261931181633,47.4566777939665,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-12,3.4200000762939453,3.4200000762939453,3.2799999713897705,3.3299999237060547,15394,0.0,0.0,3.3860000133514405,3.4865000188350677,6.2555833538373316,-1.6538715128343224,-2.882547108581599,-44.26578910987796,45.08390940997346,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-13,3.2799999713897705,3.2899999618530273,3.109999895095825,3.119999885559082,56005,0.0,0.0,3.35,3.470750015974045,6.178666683038076,-6.865675057937852,-3.479075572089485,-43.82687731801284,37.93486419923126,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-16,3.0999999046325684,3.190000057220459,3.0199999809265137,3.0799999237060547,50005,0.0,0.0,3.3119999885559084,3.4547500133514406,6.106416682402293,-7.0048329001054706,-4.1319928864274305,-43.42426675029446,36.73980822572399,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-17,3.069999933242798,3.2100000381469727,3.069999933242798,3.109999895095825,8998,0.0,0.0,3.2929999828338623,3.4407500088214875,6.035666678349177,-5.557245329243896,-4.294122665372948,-42.99304132940337,38.30949847698596,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-18,3.1600000858306885,3.200000047683716,3.119999885559082,3.200000047683716,8608,0.0,0.0,3.2609999895095827,3.4287500083446503,5.965666675567627,-1.8705900650751177,-4.892454055466552,-42.52528351295443,42.887946822490214,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-19,3.119999885559082,3.4200000762939453,3.0,3.390000104904175,132692,0.0,0.0,3.259999990463257,3.4215000092983248,5.898083343108495,3.987733583472941,-4.720152517789648,-41.98962933787444,51.13328272102207,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-23,3.380000114440918,3.380000114440918,3.0399999618530273,3.2200000286102295,35081,0.0,0.0,3.2419999837875366,3.403000009059906,5.836583340168,-0.6785920816571135,-4.731120330406538,-41.6953410801129,44.888772549971556,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-24,3.640000104904175,3.640000104904175,3.1500000953674316,3.4000000953674316,18626,0.0,0.0,3.2519999980926513,3.393000012636185,5.775750009218852,4.551048504353774,-4.155614913599243,-41.254382422706776,51.625097630166266,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-25,3.4800000190734863,3.4800000190734863,3.2100000381469727,3.3499999046325684,25668,0.0,0.0,3.258999991416931,3.383000010251999,5.712000008424123,2.792264911178257,-3.665386297939476,-40.77380943167522,49.80400960063288,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-26,3.299999952316284,3.380000114440918,3.200000047683716,3.2799999713897705,101253,0.0,0.0,3.247999978065491,3.3710000097751616,5.646833338340124,0.9852214759970166,-3.6487698413823058,-40.30282447177623,47.288993484794496,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
2025-06-27,3.2899999618530273,3.2899999618530273,3.1600000858306885,3.2100000381469727,68752,0.0,0.0,3.2359999895095823,3.352500009536743,5.5819166719913484,-0.8034595626358452,-3.4750192302984937,-39.93998465869719,44.849930998082336,,-0.116,-1.5869299,0.99824,-1.2372,,9.846625,-4.0125,AcouSort AB (publ),Healthcare,"AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden."
